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Abstract
All cells require means to obtain nutrients, dispose of waste, and communicate with
other cells. One mechanism fulfilling these requirements is active transport, and many
permeases in proteomes provide this function. One family of permeases is the
Oligopeptide Transport (OPT) family, which is characterized by transporting
tetra/penta-peptides across the plasma membrane.
In this research, an informatic approach was taken to identify 103 family members,
all from plant or fungal species with sequence homology to OPTs of known function.
Eighteen conserved motifs were identified in these homologues. Using several
computational algorithms and multiple sequence alignment, 12 transmembrane domains
have been identified in the family, with the termini predicted to be outside of the cell.
Most, but not all, of the conserved motifs lie in the non-transmembrane loops of the
proteins.
One OPT family member in the yeast Saccharomyces cerevisiae, Opt1p, was further
characterized and found to transport Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu) and
reduced glutathione (γ-Glu-Cys-Gly). The uptake of these substrates was inhibited by
substrates of other OPTs (i.e. KLGL) and substrates that inhibit Leu-enkephalin uptake
into mammalian brain (i.e.. naloxone, naltrexone, and morphine). A screen was
conducted to identify an OPT functional homologue in rat brain, but none was found.
The expression of the gene encoding Opt1p, OPT1, was characterized using a
reporter construct with the promoter of OPT1 cloned up-stream of lacZ, the gene
encoding β-galactosidase. When sulfur was absent from the medium, OPT1 was upregulated. Additionally, when naturally occurring amino acids were added to the sulfurfree medium, OPT1 was further up-regulated, up to 30-fold. Furthermore, this induction
was dependent on the presence of PTR3 and SSY1, genes encoding Ptr3p and Ssy1p.
These proteins form the SPS complex with Ssy5p to sense extracellular amino acids.
The complex transduces the signal to up-regulate amino acid and the di/tri-peptide
permease genes.
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The OPT family is a relatively new family of transporters. This study of its structure,
function, and regulation lays the groundwork and defines future areas of investigation.
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Chapter 1
Characteristics of the Oligopeptide Transport family.
Background and Significance
Active transport is a mechanism by which cells may obtain nutrients, dispose of
waste, and mediate cell-cell communication. These are needs of every cell, and
therefore permeases pervade the proteomes of every species and cell type. The
Transport Classification Database (TCDB) (tcdb.ucsd.edu/index.php) lists over 360
transporter families, each identifed by a “TC” number. One specific cellular transport
need is the uptake of peptides from the environment. The TCDB lists three families of
peptide transporters: ABC (TC #3.A.1), PTR (TC #2.A.17), and OPT (TC #2.A.67).
Members of the ABC (ATP binding cassette) transporter superfamily transport a
large variety of substrates, from carbohydrates, amino acids, and peptides, to ions, lipids,
and proteins. The superfamily is currently divided into 212 families. An ABC
transporter protein is composed of two domains that bind and hydrolyze ATP
(nucleotide binding domains) and two domains that usually make up 12 transmembrane
domains (TMDs) (Dassa and Bouige 2001). Permeases in the PTR (peptide transport)
family have 12 TMDs and transport di- and tripeptides using the proton gradient, and
this family is a member of the Major Facilitator Superfamily (Chang et al. 2004). All PTR
family members contain the conserved motif FYXXINXGSL (Hauser et al. 2001). The
OPT (oligopeptide transport family) is the newest member of the peptide transport
families. Members of this family have the ability to transport tetra- and pentapeptides.
History of the OPT family.
During studies of peptide transport in Candida albicans, it was noted that this yeast
was able to transport peptides consisting of two to five amino acid residues. The
cloning of a peptide transporter gene, CaPTR2, accounted for the phenotype of di- and
tripeptide transport, but clearly, a second transporter responsible for tetra- and
pentapeptide uptake was present in the organism. It was this observation that led
Lubkowitz et al. (1997) to clone CaOPT1, the tetra-/pentapeptide transporter from C.
1

albicans. CaOPT1 was cloned by heterologous expression of a C. albicans genomic library
in an oligopeptide transport deficient strain of Saccharomyces cerevisiae. The predicted
protein (CaOpt1p) was characterized as containing 12 to 14 TMDs. It was not a
member of either the ABC or the PTR membrane transport families: CaOpt1p contains
neither the nucleotide binding domains of the ABC family nor the conserved PTR family
motif.
The Schizosaccharomyces pombe OPT homologue ISP4 was subsequently cloned and
identified by function as an oligopeptide transporter (Lubkowitz et al. 1998), as were the
two S. cerevisiae ORFs YJL212C and YPR194C, later named OPT1 and OPT2, respectively
(Hauser et al. 2000). Since neither OPT1 nor OPT2 were expressed well under standard
conditions in strains with auxotrophic requirements, they were cloned and expressed
from the constitutive promoter ADH in the plasmid pDB20 (Becker et al. 1991). The
phenotype of strains expressing these OPTs was similar to that of the S. cerevisiae strain
expressing CaOPT1: they were able to transport tetra- and pentapeptides.
The focus of this dissertation is the study of OPT family members, especially those in
S. cerevisiae, and the search for other proteins that may share the family’s transport
characteristics. Also included is a study of TMD locations in the family.
Materials and Methods
Algorithms used.
Using Opt1p as the query, a Position Specific Iterative-Basic Local Alignment
Sequence Tool (PSI-BLAST) search (Altschul et al. 1997; Schaffer et al. 2001) of the nonredundant, protein database at National Center for Biotechnology Information (NCBI;
www.ncbi.nlm.nih.gov/) was conducted on 1 February 2005, until no new sequences
were found. Sequences were inspected individually for overall conservation before
being included in each subsequent iteration of the algorithm. Protein sequences
reported after the last iteration were retrieved from GenBank. The algorithms
ClustalW (ClustalX; www.embl.de/~chenna/clustal/darwin) and DrawTree (Phylip;
evolution.genetics.washington.edu/phylip.html) were used to align and visualize the
family.
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In vivo DNA manipulations.
Escherichia coli was often used for amplification of plasmid: all plasmids used in this
dissertation were designed for yeast expression but also could be shuttled through E.
coli. E. coli transformations were carried out using DH5α heat-shock competent cells
(Gibco/Invitrogen; Carlsbad, CA). The manufacturer’s protocol was followed with 10
ng plasmid DNA. For plasmid preps, Wizard® Plus SV Miniprep DNA Purification spin
columns (Promega; Madison, WI) were used. E. coli containing plasmid was maintained
on LB Amp (Appendix 1).
Yeast was also employed to aid in DNA manipulation. Yeast transformations were
performed following the Gietz lab protocol (Gietz and Woods 2002). In brief, cells to
be transformed were harvested in log phase and made competent with lithium acetate.
From 1 to 4 µg of linear or plasmid DNA was used in the transformation; twice as much
insert to linearized plasmid (2:1) was used when making use of homologous
recombination. When transforming yeast with linear DNA for the purpose of creating a
knock-out strain, cells were allowed to recover for two hours in YEPD (Appendix 1) at
30 C shaking at 200 rpm before plating on YEPD containing the appropriate drug
(Appendix 1). Knock-out colonies were picked and streaked for isolation after four
days of incubation; plasmid transformants and cells transformed to make use of
homologous recombination were picked after two to three days of growth on casamino
acid medium (Appendix 1). Plasmids were recovered from yeast with a Zymoprep kit
(Zymo Research; Orange, CA).
Yeast genomic DNA was obtained by the following method. A 5 mL culture of the
strain whose genomic DNA was to be purified was grown overnight at 30 C at 200 rpm
in YEPD (Appendix 1). The cells were harvested in a tabletop centrifuge at top speed
for five minutes, and they were resuspended in 500 µL of sterile water. The cells were
again pelleted at top speed, this time in a microfuge. The cells were resuspended in 300
µL breaking buffer (2% w/v Triton X-100, 1% w/v SDS, 100 mM NaCl, 10 mM Tris-HCl
pH 8.0, 1 mM EDTA pH 8.0), and 450 mg of glass beads and 300 µL phenol/chloroform/
isoamyl alcohol (24:24:1) were added to the tube. The tube was vortexed at top speed
for three minutes. Then 100 µL TE buffer was added, and the tube was vortexed
3

briefly. The sample was again microfuged at top speed for five minutes, and the aqueous
layer was transferred to a new tube. One milliliter of ethanol was added and mixed into
the solution by inversion, and the tube was placed at -20 C for twenty minutes. The
tube was again microfuged at top speed for three minutes, the supernatant removed,
and the pellet resuspended in 400 µL TE. Three microliters of RNase (10 mg/mL,
Ambion; Austin, TX) was mixed into the solution, and it was incubated at 37 C for five
minutes. Eight microliters of 5 M ammonium acetate and 1 mL ethanol were mixed into
the tube, and it was again incubated at -20 C for twenty minutes. The solution was then
microfuged for three minutes at top speed, and the pellet was dried. The genomic
DNA was resuspended in 100 µL sterile water.
Strain construction.
An opt1∆ opt2∆ double knock-out in the strain BY4730 (Appendix 2) was created to
study the open reading frame (ORF) YGL114W in the absence of the two confirmed
oligopeptide transporters in S. cerevisiae. Cassettes providing resistance to G418 and
hygromycinB (Appendix 3) were amplified by PCR with primers designed for
homologous recombination (Appendix 4) flanking the ORFs of OPT1 and OPT2
respectively. The reaction consisted of 2 units of RedTaq™ (Sigma-Aldrich; St. Louis,
MO), 1 pmol of each primer (Appendix 4), 200 µM dNTPs, 1x Sigma RedTaq buffer with
MgCl2, and 2 ng plasmid DNA (Appendix 3). The components were combined on ice
and immediately placed at 95 C for five minutes to begin the reaction. Forty cycles
were carried out: 1 minute at 95 C, 1 minute at 52 C for KanMX4 or 55 C for
HphMX3, and 3 minutes at 72 C. An additional seven minutes were added at 72 C for
extension, followed by a hold at 4 C. The reactions were visualized by separation of
DNA on a 1% agarose/TAE gel with subsequent staining with ethidium bromide. PCR
products were purified by SOPE column (Open Biosystems; Huntsville, AL).
Gene knock-outs were confirmed by both PCR and Southern blot analysis. Primers
were designed to anneal to sequence flanking the knocked-out region (Appendix 4).
The reaction consisted of 2 units of RedTaq™ (Sigma-Aldrich; St. Louis, MO), 1 pmol of
each primer, 200 µM dNTPs, 1x Sigma RedTaq buffer with MgCl2, and 8 ng genomic
4

DNA. The components were combined on ice and immediately placed at 95 C for five
minutes to begin the reaction. Forty cycles were carried out: 1 minute at 95 C, 1
minute at 54 C, and 3 minutes at 72 C. An additional seven minutes were added at 72
C for extension, followed by a hold at 4 C. Products were visualized by agarose gel
electrophoresis.
Twenty micrograms of genomic DNA was digested overnight in a volume of 200 µL
with 10 µL of one of two restriction enzymes chosen for each gene, one which cut only
flanking the ORF, the other which cut internally: BamHI flanked both, while KpnI cut
OPT1 and FspI cut OPT2. Buffers, BSA concentration, and temperatures were used as
dictated by the New England BioLabs Catalog (Beverly, MA). Also included was
genomic DNA from the parent strain FY2 (Appendix 2). After digestion, DNA was
precipitated with 1 mL ethanol and 30 µL ammonium acetate (5 M) by incubating at -20
C for two hours followed by centrifugation for eight minutes under vacuum.
Digested DNA was resolved on a 0.7% agarose/TAE gel in a 400 cm2 gel box. After
visualization, the gel was depurinated in acid (0.26 N HCl, 500 mL) for 20 minutes,
denatured in saline base (0.5 M NaOH, 1.5 M NaCl, 500 mL) for 30 minutes, and
neutralized in saline Tris buffer (0.5 M Tris-HCl pH 7.5, 1.5 M NaCl, 500 mL) for at least
30 minutes, all while gently shaking. The solutions were decanted after each step. The
DNA was blotted overnight to a positive nitrocellulose membrane (Osmonics/GE
Water Technologies; Piscataway, NJ) overnight in 20x SSC (175.3 g sodium chloride and
88.2 g sodium citrate per 1 L, pH 7.0) by capillarity action, then air dried before the
DNA was cross-linked to the membrane using a UV Stratalinker (Stratagene; La Jolla,
CA) set to 1200 kJ.
Probes were constructed by PCR from amplification of the ORF from genomic DNA
using probe primers specific for each gene (Appendix 4). The following conditions were
used: 2 units of RedTaq™ (Sigma-Aldrich; St. Louis, MO), 1 pmol of each primer
(Appendix 4), 200 µM dNTPs, 1x Sigma RedTaq buffer with MgCl2, and 8 ng genomic
DNA obtained as described above. The components were combined on ice and
immediately placed at 95 C for five minutes to begin the reaction. Forty cycles were
carried out: 1 minute at 95 C, 1 minute at 55 C, and 3 minutes at 72 C. An additional
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seven minutes were added at 72 C for extension, followed by a hold at 4 C. PCR
products were purified by SOPE column (Open Biosystems).
Purified PCR product was labeled using a random-prime labeling technique as
follows. Fifty nanograms of DNA was incubated for 1 hour at 37 C with 3 µg random
9-mer or 5 µg random 6-mer, 1x label buffer (900 µM HEPES, 100 µM Mg), 50 nM
dNTP (no ATP), 10 mM DTT, 3 µL 32P dATP, and 1 µL Klenow enzyme (Fisher
Scientific; Hampton, NH) in 20 µL. A spin-column purification was performed to purify
the radioactive probe — either Bio-Spin® chromatography columns (Bio-Rad; Hercules,
CA) or ProbeQuant micro columns (Amersham/GE Heathcare; Piscataway, NJ) were
used.
The membrane was washed in 2x SSC and placed into a hybridization bag (Roche;
Indianapolis, IN) along with 25-30 mL prehybridization solution [1x HPB (5x HPB is
146.1 g sodium chloride, 134.0 g disodium hydrogen phosphate, and 9.3g EDTA per 1L,
pH 7.0), 1% sarkosyl, 200 µg/mL boiled herring sperm DNA (Promega)], sealed, and
incubated while shaking at 65 C for 4 hours. The probe was boiled for five minutes
then added to the bag and the bag resealed. Hybridization took place overnight, shaking
at 65 C. The blot was rinsed three times with 0.1% SDS, 0.1x SSC (1 L total) at 65 C.
The blot was then wrapped in plastic wrap and placed in a cassette against a Molecular
Dynamics phosphor screen (Amersham/GE Heathcare) overnight. The screen was
analyzed on a STORM 840 densitometer with ImageQuant (Amersham/GE Heathcare).
Plasmid construction.
The S. cerevisiae ORF YGL114W was cloned into the vector pDB20 for constitutive
expression (Appendix 3) in a manner similar to the cloning of OPT1 and OPT2
(Lubkowitz et al. 1998; Hauser et al. 2000). Primers were designed to amplify YGL114W
from genomic DNA and to make use of homologous recombination for plasmid
construction (Appendix 4). PCR conditions were as follows: 2 units of Pfu DNA
polymerase (Stratagene; La Jolla, CA), 1 pmol of each primer, 200 µM dNTPs, 1x buffer
supplied with enzyme, 2.5 mM MgCl2, and 8 ng genomic DNA. The components were
combined on ice and immediately placed at 95 C for five minutes to begin the reaction.
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Forty cycles were carried out: 45 seconds at 95 C, 45 seconds at 55 C, and 3.5 minutes
at 72 C. An additional seven minutes were added at 72 C for extension, followed by a
hold at 4 C. The reaction was visualized by separation of DNA on a 1% agarose/TAE
gel with subsequent staining with ethidium bromide. PCR products were purified by
SOPE column (Open Biosystems). The parent plasmid, pDB20, was linearized with 2 µL
of NotI in a 20 µL reaction, and it and the YGL114W PCR product were co-transformed
into FY2 (Appendix 2). Plasmid was isolated from transformants and sequenced
(Appendix 4; Sanger et al. 1977). In line with cloned OPT1 and OPT2, the plasmid
containing the ORF YGL114W was named pADH114w (Appendix 3).
Growth assays.
Cells were grown overnight in 50 mL of poor nitrogen medium with appropriate
free amino acids to satisfy auxotrophic requirements (Appendix 1) at 30 C shaking at
200 rpm. Cultures were harvested by centrifugation for five minutes at top speed in a
tabletop centrifuge, washed twice with water, and resuspended at 2x106 cells per mL.
Cells were then spotted in 5 µL spots onto a variety of agar media, all with poor
nitrogen medium as a base (Appendix 1). These media contained methionine to fulfill
the auxotrophic requirement and one of the following: no leucine, 230 µM leucine, 300
µM Leu-enkephalin (YGGFL), or 300 µM KLGL. Plates were observed for growth for
up to four days.
Uptake assays.
Cells were grown overnight in 50 mL of poor nitrogen medium with appropriate
free amino acids to satisfy auxotrophic requirements (Appendix 1) at 30 C shaking at
200 rpm. Cultures were harvested at 4 C by centrifugation at top speed in a tabletop
centrifuge, washed twice with cold 2% glucose, and resuspended at 2x108 cells per mL.
These cells were then combined with an equal part of 2x uptake medium (2% glucose,
400 µM citric acid/potassium phosphate buffer pH5.5, 250 µM [3H]-Leu-enkephalin or
reduced [3H]-glutathione at 1 µCi per mL) and incubated for the appropriate time at 30
C, after which the cells were filtered using a vacuum manifold fitted with 0.45 µm
7

nitrocellulose filters (Millipore; Billerica, MA). These were then washed with 4 mL of
ice cold water. Filters were dissolved with CytoScent (MP Biomedicals; Irvine, CA) and
counted with a scintillation counter.
If inhibitors were added, they were added to the cells simultaneously with the
radiolabeled substrates, final concentration as follows: 100 µM carbonyl cyanide 3chlorophenylhydrazone (CCCP), 2.5 mM tyrosine, 2.5 mM Gly-Gly-Phe, 2.5 mM GlyGly-Phe-Leu, 2.5 mM Lys-Leu-Gly-Leu, or 2.5 mM Leu-Leu. In assays using glutathione
(GSH; γ-Glu-Cys-Gly), all tubes containing it were purged with nitrogen to keep the
GSH in its reduced form until it was combined with cells.
Results
The OPT family is found in multiplicity in fungal and plant species.
To obtain a current list of OPT family members, PSI-BLAST was employed to search
the non-redundant protein database at NCBI on 1 February 2005, with Opt1p used as
the query. All default settings were retained. The search was repeated until no new
proteins were obtained — in this instance, the program was executed eight times.
Before each successive iteration, each alignment was inspected for overall homology,
and those subjects with weak homology (less than 40% identical/similar to Opt1p) or
those with strong homology over only a very short region (less than 40% of the length
of Opt1p; bit score less than 200) were omitted. The final iteration yielded 81 unique
fungal and 22 unique plant proteins (Table 1-1) with minimum scores of 452 bits. (Evalues were not used because as the dataset in a database grows, an e-value for a certain
query retrieving a certain subject changes. E-values represent the likelihood that the
subject would be found in the given dataset by random chance. Bit scores, however,
remain constant since they reflect the pairwise alignment score). Sequences that
appeared to be truncations of these 103 proteins were removed from the list. Likely
truncations were defined as sequences that were identical to a represented protein but
were less than three-fourths of the length of that protein. Only one copy of pairs of
sequences with only one residue different between them was retained, since these
differences were likely either allelic variation or sequencing error.
8

Table 1-1. Genomes containing OPT homologues. Genomes listed are
those found to contain hypothetical members of the OPT family by PSI-BLAST analysis.
The number of potential OPTs in each, as of 1 February 2005, is listed. ORF
translations that differed by one amino acid and those that appeared to be a truncation
of a protein already represented (were identical to, but less than three-fourths as long
as a represented protein) were removed from this dataset.

Fungal genomes
Species a
Number of OPTs
Yarrowia lipolytica b
17
Gibberella zeae
9
Magnaporthe grisea
8
Neurospora crassa
8
Candida albicans
7
b
Cryptococcus neoformans
6
Aspergillus nidulans
5
Ustilago maydis
5
Ashbya gossypii b
4
Schizosaccharomyces pombe b
4
b
Kluyveromyces lactis
3
Debaryomyces hansenii b
2
b
Saccharomyces cerevisiae
2
Schizophyllum commune
1
Plant genomes
Species
Number of OPTs
b
Oryza sativa
11
Arabidopsis thaliana b
9
Brassica juncea
1
Zea mays
1
a
Spizellomyces punctatus and Candida glabrata have been completely sequenced but PSIBLAST did not return an OPT homologue from either genome.
b
Genomes reported by the European Molecular Biology Laboratory website (EMBL;
www.ebi.ac.uk/embl/) to be complete as of 1 February 2005. All other species included
in this table contain OPTs as indicated but do not have a completely sequenced genome.

9

An unrooted phylogenetic tree was created (Figure 1-1) using the alignment
program ClustalX and the tree-drawing program DrawTree from Phylip, with all default
settings retained. All 22 plant members are segregated from the fungal members and
grouped relatively tightly in comparison. All but one of the OPT members found in Y.
lipolytica also are grouped in their own branch. All homologues from other species are
distributed throughout the rest of the tree.
Multiple OPT homologues were found in each plant or fungal genome that has been
completely sequenced (Table 1-1), except Spizellomyces punctatus and Candida glabrata.
PSI-BLAST only queries protein sequences, not nucleotide entries, and if a putative OPT
member has not yet been annotated as an ORF, it would not be found by PSI-BLAST.
Conserved motifs and single residues in the OPT family.
Upon retrieval of the results from the PSI-BLAST search and analysis of the proteins
by multiple-sequence alignment with ClustalW, 18 conserved motifs were found in the
OPT family (Figure 1-2). These motifs contained at least three residues found in more
than half of the 103 family members, spread over no fewer than four residues. If there
were more than four non-conserved residues in a row, the motif ended. Most residues
were not 100% conserved; frequently, these residues were replaced with an amino acid
with similar attributes, i.e. if arginine were the conserved residue, it was often
substituted with a lysine. Additionally, there were 28 amino acid residues that were
highly conserved but not part of a motif as defined above (Table 1-2). Each of these
single, conserved residues was present in at least 60% of the family — nine were found
in at least 90% of the family. All conserved motifs or single residues are found
consecutively in the primary sequences of OPT family members.
A large number of proteins that are members of an iron-phytosiderophore transport
family were found by the PSI-BLAST search, with bit scores below 452. All of these
contained the sequence X4PFTRQEX in place of the LNPGP[F/W/Y][N/S/T]XKE[H/Q]
motif. Since the iron-phytosiderophore transporter motif overlaps with the OPT motif,
PSI-BLAST gives the family a higher score for the region. Unfortunately, many of these
putative proteins have already been labeled in NCBI databases as oligopeptide
10

Figure 1-1. Unrooted phylogenetic tree of the OPT family. In the
phylogenetic tree, OPT members found in plant species have their own branch and are
marked accordingly; the rest are fungi. Similarly, 16 of the 17 members found in Y.
lipolytica are grouped together and are labeled. All other species with multiple members
are distributed throughout the rest of the tree. ORF translations not from a plant or
named in a database are represented by the first letter of their genus and first two
letters of their species name as listed in Table 1-1. Those fungal members that have
been named in databases or in the literature have been labeled, such that Opt1p and
Opt2p are from S. cerevisiae, CaOpt1p through CaOpt7p are from C. albicans, Isp4p is
from S. pombe, and Mtd1p is from S. commune. ClustalW with default parameters in
ClustalX and DrawTree from the phylogeny package Phylip were used to create this
tree.
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Figure 1-2. Conserved motifs of the OPT family. Eighteen conserved motifs
of the OPT family are shown. The percent listed under each conserved residue
(represented by the single letter code for amino acids) is the frequency at which it is
conserved in all members. If there were no conserved residue in a location, an X is set
in the position; if more than one residue in a row could be any amino acid, the number
of Xs in a row is represented by subscript. The corresponding residue number of
Opt1p is found in bold to the left of the motif.
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Table 1-2. Single, conserved residues of the OPT family. Twenty-eight
single, conserved residues were found in over 60% of the 103 OPT family members, but
were not assigned to the motifs listed in Figure 1-2. These residues were consecutive in
the linear sequence of family members.

Residue

Percent
conserved

T
R
Q
P
G
P
F
Y
D
W
P
N
G
Y
F
P
W
P
T
V
V
C
Y
G
K/R
P
F
F

96
99
75
84
95
90
62
79
98
93
98
76
84
73
81
85
85
86
77
62
65
82
97
98
73
75
65
71

Residue
number in
Opt1p
106
108
142
147
149
157
204
205
335
336
351
357
361
432
436
508
510
525
533
606
610
622
658
668
680
683
755
756
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transporters, even though they are more closely related to the iron-phytosiderophore
transporters.
YGL114W cannot support growth on known substrates of the OPT
family.
Growth assays were conducted to determine if the S. cerevisiae ORF YGL114W is an
OPT. The ORF was cloned into the constitutive expression vector pDB20 (Appendix
3), and cells containing pADH114w were challenged to grow on Leu-enkephalin
(YGGFL) and KLGL, known substrates of other OPT family members, as the sole
sources of leucine (Figure 1-3). Unlike cells expressing CaOPT1 from C. albicans or OPT1
from S. cerevisiae, cells containing YGL114W under a constitutive promoter could not
grow on these media.
Opt1p transport characteristics.
When over-expressed from a constitutive promoter (pADH212c, Appendix 3) in
the strain BY4730 (Appendix 2), OPT1 from S. cerevisiae supports the transport of both
Leu-enkephalin, a pentapeptide, and reduced glutathione (Figure 1-4). Cells were
incubated for one to 12 minutes with 250 µM of either [3H]-Leu-enkephalin or [3H]glutathione. Only cells that expressed Opt1p were able to accumulate substrate.
The Km of GSH for Opt1p was determined to be 110 µM (Figure 1-5). Five
concentrations of GSH, from 5 to 750 µM, were tested in quadruplicate over four timepoints, ranging from one to nine minutes. The velocity was determined for each
concentration by ascertaining the slope of substrate transported per minute. Velocity
was plotted verses substrate concentration, and the Km determined by plotting one-site
binding with Prism (GraphPad Software; San Diego, CA).
Leu-enkephalin and GSH compete for uptake by Opt1p, inhibiting each other (Figure
1-6). When Leu-enkephalin uptake was measured, 25 to 500 µM of cold GSH was
added to the uptake medium — corresponding to 0.1 to 2x the concentration of
Leu-enkephalin (250 µM). The Ki of GSH for Leu-enkephalin was measured as 83 µM.
When GSH transport was measured, 0.25 to 5 mM cold Leu-enkephalin was added —
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Figure 1-3. Ygl114wp cannot use OPT family substrates to support
growth in the absence of leucine. In rows, 104 cells of the strain BY4730 (ura3Δ
leu2Δ met15Δ, Appendix 2), either expressing CaOPT1, OPT1, or YGL114W from a
constitutive promoter or containing the empty vector pDB20 (Appendix 3), were
grown on poor nitrogen medium supplemented with methionine (Appendix 1). In
columns, the medium was supplemented with 230 µM leucine, no leucine, 300 µM
YGGFL, or 300 µM KLGL. Growth was observed on medium containing free leucine,
while none was seen on medium without any leucine present. Cells overexpressing
CaOPT1 grew well on medium containing KLGL and very poorly on medium with
YGGFL. Cells overexpressing OPT1 grew well on medium containing YGGFL and
poorly on medium with KLGL. Cells harboring YGL114W under a constitutive
promoter do not grow on medium with either YGGFL or KLGL as the sole source of
leucine.
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Figure 1-4. Opt1p transports Leu-enkephalin and glutathione. Cells of
the strain BY4730 (Appendix 2)either constitutively expressing OPT1 or containing
empty vector (Appendix 3)were incubated in the presence of either 250 µM [3H]-Leuenkephalin (A) or 250 µM [3H]-glutathione (B). Only cells over-expressing OPT1
accumulated substrate over time.
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Figure 1-5. Determination of Km of reduced glutathione for Opt1p.
The Km of GSH for Opt1p was determined by uptake assays conducted in the linear
range of transport. In quadruplicate, five concentrations of GSH (5-750 µM) were
evaluated over four time-points (one to nine minutes). The slope of the line for each
concentration (nmol substrate transported per mg dry weight of cells per minute),
representing velocity, was determined and plotted below verses substrate
concentration. The Km of was determined to be 110 µM.
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Figure 1-6. Leu-enkephalin and glutathione compete for uptake by
Opt1p. Cells constitutively expressing Opt1p were incubated with either [3H]-Leuenkephalin and non-radiolabeled GSH (A [left] and B) or [3H]-glutathione and nonradiolabeled Leu-enkephalin (A [right] and C) for 12 minutes. A. Non-radiolabeled
substrate was present at concentrations from 0.1 to 2x (in the case of GSH) or 1 to 20x
(in the case of Leu-enkephalin) as compared to the concentration of radiolabeled
substrate present (250 µM). These data were transformed and plotted as velocity
(nmol/mg dry weight of cells/min) verses log[substrate] to determine the Kis of GSH’s
inhibition of Leu-enkephalin (83 µM, B) and Leu-enkephalin’s inhibition of GSH (935
µM, C).
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1 to 20x the concentration of GSH present (250 µM). The Ki of Leu-enkephalin for
GSH was determined to be 935 µM.
To determine if Opt1p was using the proton-gradient as an energy source for
peptide transport, the protonophore CCCP was incubated with the cells during an
assay. With the proton-gradient abolished, Leu-enkephalin uptake by over-expressed
Opt1p was inhibited (Figure 1-7), demonstrating that the permease does use the
proton-gradient.
Peptides that are transported by Opt1p are either tetra- or pentapeptides. A
substrate of Ptr2p, dileucine, does not inhibit Leu-enkephalin uptake (Figure 1-7), nor do
the truncations of Leu-enkephalin tyrosine and Gly-Gly-Phe. The tetrapeptide
truncation Gly-Gly-Phe-Leu, however, does inhibit transport of Leu-enkephalin. In
addition, the tetrapeptide Lys-Leu-Gly-Leu (KLGL), a known substrate of other OPT
members, inhibits Leu-enkephalin transport by Opt1p. Further characterization of
inhibitors of Opt1p transport may be found in Chapter 3.
Characteristics of other family members.
An uptake assay was performed to ascertain whether other OPTs – AtOPT1-7 from
A. thaliana, CaOpt1p from C. albicans, and Opt2p from S. cerevisiae – transported GSH in
a manner similar to Opt1p from S. cerevisiae (Figure 1-8). When expressed from a
constitutive promoter in S. cerevisiae, they do not support transport, and Opt1p remains
the only family member that has been observed to transport GSH. AtOPT4, however,
does transport the tetrapeptide KLGL, although it does so poorly (Figure 1-9). To
observe transport of KLGL by AtOPT4, the incubation time was increased from the
normal 12 minutes to 30 minutes.
Discussion
Our laboratory first identified the Oligopeptide Transport (OPT) system in 1997 in
C. albicans (Lubkowitz et al. 1997) and later established it in S. pombe (Lubkowitz et al.
1998). At that time, the ORFs YJL212C and YPR194C, both from S. cerevisiae, were
identified as potential homologues based on sequence homology. They were cloned and
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Figure 1-7. Inhibitors of Leu-enkephalin transport by Opt1p. With
uptake medium, the protonophore CCCP was added to cells over-expressing Opt1p
and incubated for 12 minutes. Likewise, truncations of Leu-enkephalin (tyrosine, GlyGly-Phe, and Gly-Gly-Phe-Leu) or known substrates of other peptide transporters (LysLeu-Gly-Leu, CaOpt1p; Leu-Leu, Ptr2p) were added at a 10x concentration to that of
the 250 µM [3H]-Leu-enkephalin. Bars represent percent of Leu-enkephalin transported
as compared to control.
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Figure 1-8. Opt1p is the only family member known to transport
glutathione. Cells of the strain BY4730 (Appendix 2) constitutively expressing OPT1
or OPT2 from S. cerevisiae or AtOPT1-7 from A. thaliana, or cells of the same strain
expressing CaOPT1 from its native promoter, and cells containing the empty vector
pDB20 were incubated in uptake medium for 12 minutes with 250 µM [3H]-glutathione.
Only cells over-expressing Opt1p from S. cerevisiae accumulated the substrate over
time.
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Figure 1-9. AtOPT4 transports KLGL. Cells of the strain BY4730, expressing
CaOPT1 from its own promoter, AtOPT4 from a constitutive promoter, or the empty
vector pDB20, were incubated with 500 µM [3H]-KLGL for 30 minutes at 30 C or 0 C.
CaOPT1 was used here as a positive control. Cells harboring the plasmid containing
AtOPT4 were able, albeit poorly, to accumulate KLGL while at 30 C.
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determined to be OPT members by functional analysis, namely uptake and growth
assays, and therefore named Opt1p (Hauser et al. 2000) and Opt2p, respectively.
A multiplicity of OPTs.
By PSI-BLAST analysis, the family has now been extended to 81 fungal and 22 plant
members, the plant members comprising their own branch. This seems to imply a single
ancestor before the fungi and plant kingdoms were formed. This new PSI-BLAST
analysis yielded no new OPT members in A. thaliana; in 2002, we identified and named
AtOPT1 through 9 (Koh et al. 2002). Zhang et al. (2004) have recently cloned and
confirmed the first OPT member in O. sativa — OsGT1. It is likely that as more plant
genomes near sequence and annotation completion, more OPT members will be added
to this small OPT sub-section.
The fungal family members are not grouped by species, with two exceptions: OPTs
in Y. lipolytica are more closely related to each other than to OPTs in any other
organism and some of the OPTs found in C. albicans form a cluster. The three most
closely related C. albicans proteins — CaOpt2p, CaOpt3p, and CaOpt4p — are the top
three unique C. albicans OPT members to be up-regulated when the cell is phagocytosed
by macrophages (Lorenz et al. 2004). These three are the same three also up-regulated
in the opaque as compared to white phase of the yeast (Tsong et al. 2003). OPTs in C.
albicans are not up-regulated, however, when the cell is phagocytosed by neutrophils
(Rubin-Bejerano et al. 2003). Perhaps these OPTs are involved in virulence or even
mating — C. albicans cells in opaque phase are the only cells that have been observed to
mate (Soll et al. 2003) . Two OPTs in other species, Isp4p in S. pombe and Mtd1p in S.
commune, were originally identified in screens to search for proteins involved in mating
(Sato et al. 1994; Lengeler and Kothe 1999). In fungi, conditions for mating are also
conditions in which the cell is starving for nutrients. In the past, the idea that OPTs
were involved in mating was dismissed the the argument that the genes were simply upregulated during starvation conditions. Now that three C. albicans OPTs have been
observed to be up-regulated in both opaque phase cells and cells that have been
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phagocytosed by macrophages, proteins encoded by these genes are implicated in either
the mating process or virulence.
Because of the multiplicity of family members in each species, it is surprising that no
OPTs were found in the two completed genomes S. punctatus and C. glabrata. If these
species have the ability to transport oligopeptides, they must do so utilizing permeases
unrelated to the OPT family.
OPT familial motifs.
The “SPY,” or SPYXEVR[A/S][A/V]VX3DDP, conserved motif was first reported in
1998 (Lubkowitz et al. 1997). We have later referred to the “NPG” motif
(NPG[P/A]F[N/T/S]XKEH[V/T/A][L/I/V][I/V]I[T/S/V][I/V/M][F/M][A/S][N/S/A]) and the
“KIPPR” motif (K[L/F][G/A][H/M/T]YMK[I/V/L][P/D/S]PR) (Koh et al. 2002). Here,
having over ten-fold the number of homologues from which to draw, we wish to clarify
the OPT family motifs. When analyzing 103 OPT homologues, the “SPY” motif is
altered to SPYXEVRXV[V/T]X3D[D/E]P. In addition, the “NPG” motif is now shortened
to LNPGP[F/W/Y][N/S/T]XKE[H/Q]; the last nine residues of the motif as we
previously reported are mainly hydrophobic but not conserved enough to be included in
the motif. The “KIPPR” motif has been lengthened and modified. It now stands as
QGX2FX2DXKX2HYXKXPPRX2FX2Q[V/I/L], the section underlined representing the
residues of the motif as it formerly was reported. Furthermore, 28 single residues were
also conserved, present in at least 60% of the family members. These amino acid
residues were more than four residues away from a motif, but due to their
conservation, they are likely important in function of the transporters.
The PSI-BLAST iterations yield a group of proteins below the bit score of 452. Most
of these proteins contained a X4PFTRQEX motif, in place of the “NPG” motif
(LNPGP[F/W/Y][N/S/T]XKE[H/Q]) identified for the OPT family. These proteins did
not, however, contain any of the other OPT conserved motifs, although they did have
an overall weak homology (less than 40% identity/similarity) to Opt1p, mainly in the
hydrophobic stretches. Many of the PFTRQE containing proteins had been labeled as
members of an iron-phytosiderophore transport family — some had also been labeled
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as OPT members. It has even been published that one of these confirmed ironphytosiderophore transporters, Yellow Stripe 1 (YS1) from Z. mays, is an OPT member
on the basis of a BLAST alignment report (Yen et al. 2001). It is not surprising that a
transporter with a large number of TMDs hits another transporter with a large number
of TMDs during a BLAST search. BLAST searches are the only evidence there is for
these iron-phytosiderophore transporters being part of the OPT family. Because YS1
homologues do not contain any of the OPT family motifs and transport different
substrates, I propose that they constitute a family separate from the OPTs.
Substrates of OPTs.
We have identified the S. cerevisiae protein Opt1p as a transporter of the
pentapeptide Leu-enkephalin (Hauser et al. 2000). The Km of the pentapeptide was
calculated to be 310 µM. The transport was determined to be dependent on both
temperature, suggestive of active transport, and pH. Bourbouloux et al. (2000)
determined that GSH was also a substrate of Opt1p, with a Km of 54 µM. Our repeat of
this experiment, shown here, doubles that Km to 110 µM. As expected, Leu-enkephalin
and GSH compete with each other for transport by Opt1p.
Our work suggests that Opt1p is unique in its ability to transport GSH. A recent
paper by Cagnac et al. (2004) describes the ability of AtOPT6 to uptake GSH. Although
we only witnessed the ability of AtOPT6 to grow on KLLLG as the sole source of
leucine (Koh et al. 2002), Cagnac et al. have shown that uptake of GSH by the
permeases was inhibited by Leu-Leu, contrary to our growth assays. Zhang et al. (2004)
have also recently shown evidence that OsGT1 from O. sativa can transport glutathione
derivatives; this uptake can also be inhibited by Leu-Leu. The fact that the OPTs that
mediate GSH uptake are not phylogenetically grouped suggests that the family did not
evolve into proteins that group by function, but rather evolved as general oligopeptide
transporters with some members converging in their capability of transporting GSH.
Saier’s lab (Yen et al. 2001) has labeled the S. cerevisiae ORF YGL114W as a putative
OPT homologue due to a BLAST result. Indeed, we have also observed this ORF in
BLAST results, albeit with a low bit score of 189 and only 11% identity. Despite it being
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retrieved via BLAST and Yen et al.’s claim that it is an OPT, here we show that the
over-expression of YGL114W is not sufficient to support growth on a tetra- or
pentapeptide as the sole source of leucine. This does not mean that YGL114W does not
encode a peptide transporter. There are 16,000 possible tetrapeptides and an
enormous 320,000 possible pentapeptides; it is impossible to test even a fraction of
these.
Another possible role for Ygl114wp is that of receptor. Snf3p and Rgt2p had initially
been thought to be hexose transporters, and it was believed that Ssy1p was an amino
acid transporter. All of these were later discovered to be receptors (Ozcan et al. 1996;
Iraqui et al. 1999). What distinguishes these three receptors from Ygl114wp, however,
is their lengthy N-termini, used in signaling. The N-terminus of Ygl114wp is predicted
to be a mere 27 residues long, and therefore it is unlikely that the protein’s N-terminus
is involved in signaling.
A niche for the OPT family.
It is difficult to propose a single biological niche for the OPT family: some members
appear to be GSH transporters while other are clearly not; some C. albicans members
are up-regulated during phagocytosis and opaque phase while the rest are not. The
small amount of data available suggests that members of the OPT family are often upregulated during times of stress and cell-wall turnover. For example, AtOPT3 is
required for embryonic development in A. thaliana (Stacey et al. 2002). This development
relies heavily on nutrients as the plant begins growth. Nutrient starvation also induces
mating in the fungi’s natural environment. The regulation of MTD1, an OPT in S.
commune, is dependent on mating-type, and its transcript levels are significantly higher in
fully compatible mated cells (Lengeler and Kothe 1999). ISP4 from S. pombe was
originally designated as a gene involved in sexual differentiation (Sato et al. 1994), but
later shown to be simply up-regulated while using proline as a nitrogen source
(Lubkowitz et al. 1998). Additionally, three OPTs from C. albicans are up-regulated in
opaque-phase cells, the only phase of Candida in which mating has currently been
observed. All of the conditions share one thing: they all place a nutrient stress on the
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cell, requiring it to scavenge nutrients from its immediate environment. Predictably,
organisms require methods to take in essential nutrients, and therefore oligopeptide
transporters are up-regulated at these times.
We have established distinct motifs covering the entire length of the proteins in the
OPT family and have identified their transport characteristics. We have discovered a
wide range of peptides that this family can uptake, from various tetra- and pentapeptides
and the tripeptide glutathione, to cyclic compounds that mimic the pentapeptide Leuenkephalin, discussed in detail in Chapter 3. This opens other lines of inquiry: the
regulation of OPT expression in S. cerevisiae, topology of family members with respect to
conserved domains, and the true function of Ygl114wp, the first two of which are
investigated in this dissertation in Chapters 2 and 4, respectively. This is the first time
the OPT family has been so extensively studied, by either computational or functional
analysis.
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Chapter 2
Regulation of the Oligopeptide Transport family in
Saccharomyces cerevisiae.
Background and Significance
Little is known about the regulation of OPT expression in S. cerevisiae (Hauser et al.
2001). While some microarray data have been gathered on various environmental
conditions that regulate OPT (to be summarized in the discussion section of this
chapter), the proteins involved have not been clearly defined. In strain backgrounds
necessary for functional studies of Opt1p and Opt2p, their transcripts are not
expressed under a number of growth conditions, requiring activation by an artificial
constitutive promoter to observe the transport phenotype they mediate (Lubkowitz et
al. 1998; Hauser et al. 2000; Chapter 1). The conditions that allow native expression of
these proteins are not known.
In other organisms that have a multiplicity of OPTs, however, some information has
been generated regarding expression of OPT genes. Stacey et al. (2002) found that
AtOPT3 is expressed during and required for embryonic growth of A. thaliana, which
has nine OPTs. Lorenz et al. (2004) observed up to 30-fold induction of three of the
nine C. albicans OPTs upon phagocytosis by macrophages and no induction of other
family members in the same species. We hypothesize that the multiplicity of OPTs in A.
thaliana and C. albicans may allow differential expression under various environmental or
developmental conditions.
Regulation of the di/tri-peptide transporter in S. cerevisiae.
The regulation of the gene encoding the other peptide transporter in yeast, PTR2, is
better understood than OPT1 or OPT2. Transcript levels of PTR2 are increased when
cells are grown on the poor nitrogen source allantoin (Island et al. 1987). Levels of
Ptr2p at the membrane drop dramatically within 30 minutes after the addition of a rich
nitrogen source, such as ammonium sulfate (Minkin and Becker, unpublished). In
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addition, PTR2 expression is increased when cells are exposed to tryptophan or leucine.
PTR2 RNA levels peak at 40 minutes when induced with leucine (Perry et al. 1994), but
dipeptide transport peaks at four hours when induced with tryptophan (Island et al.
1987).
It is not known which proteins regulate the nitrogen response of PTR2, but the
amino acid response is regulated through the amino acid receptor Ssy1p (Didion et al.
1998). Ssy1p is an integral membrane protein that interacts with Ptr3p and Ssy1p to
form the SPS complex (Forsberg and Ljungdahl 2001). Ssy1p is also required for the
induction of genes encoding amino acid transporters, AGP1, BAP1, BAP2, GAP1, GNP1,
TAT1, and TAT2 in S. cerevisiae (Kodama et al. 2002). Upon receptor activation by amino
acids, the signal is transduced, presumably by the SPS complex processing the
transcription factors Stp1p and Stp2p, which then migrate to the nucleus. Then, a
complex interaction with the repressor Cup9p initiates transcription of PTR2.
Regulation of OPT1.
Preliminary microarray data from our lab indicated that Ptr3p is required for
expression of OPT1 (Goldstein and Becker, unpublished). The relative transcript levels
of OPT2 were not observed since the gene was not included in the data set. Both
because of this microarray data and because the SPS complex regulates amino acid and
peptide transporters in S. cerevisiae, in this chapter we investigated the roles of Ptr3p
and Ssy1p in OPT expression. Additionally, we tested the effect of starvation conditions
on OPT expression. We were also interested in whether each individual OPT or the
Ygl114wp had an effect on expression of OPT1 or OPT2. Ptr3p and Ssy1p are known to
play a role in gene expression of amino acid and di/tri-peptide transporters, and
therefore we hypothesized that these proteins were also involved in the regulation of
the OPTs. Additionally, it was hypothesized that the presence or absence of an OPT also
affected OPT1 expression. If either Opt1p or Opt2p is absent, perhaps the yeast cell is
able to ascertain that fewer oligopeptide transporters are available and the transcription
of OPT1 is increased to overcome this deficiency.
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Materials and Methods
Strain construction.
Single gene knock-outs of OPT1, OPT2, YGL114W, PTR3, and SSY1 and the double
knock-out of PTR3 and SSY1 and the double knock-out of PTR3 and OPT1 were created
in the S. cerevisiae FY2 strain background (Appendix 2) using the drug resistance
cassettes KanMX4, providing resistance to G418; HphMX3, providing resistance to
hygromycinB; and NatMX3, providing resistance to clonNAT (Appendix 3). PCR was
carried out in order to amplify the cassette with ends homologous to the genomic
region to be knocked-out. The reaction consisted of 2 units of RedTaq™ (SigmaAldrich; St. Louis, MO), 1 pmol of each primer (Appendix 4), 200 µM dNTPs, 1x Sigma
RedTaq buffer with MgCl2, and 2 ng plasmid DNA (Appendix 3). Seven percent DMSO
was included in any PCR to amplify the NatMX3 cassette due to its high G/C content.
The components were combined on ice and immediately placed at 95 C for five minutes
to begin the reaction. Forty cycles were carried out: 1 minute at 95 C; 1 minute at 52
C for KanMX4, 55 C for HphMX3, or 52 C for NatMX3; and 3 minutes at 72 C. An
additional seven minutes were added at 72 C for extension, followed by a hold at 4 C.
The reactions were visualized by separation of DNA on a 1% agarose/TAE gel with
subsequent staining with ethidium bromide. PCR products were purified by SOPE
column (Open Biosystems; Huntsville, AL).
Gene knock-outs were confirmed by PCR and Southern blot analysis (Figure 2-1).
Primers were designed to anneal to sequence flanking the knocked-out region
(Appendix 4). The reaction consisted of 2 units of RedTaq™ (Sigma-Aldrich; St. Louis,
MO), 1 pmol of each primer, 200 µM dNTPs, 1x Sigma Red Taq buffer with MgCl2, and
8 ng genomic DNA obtained as described in Chapter 1. Seven percent DMSO was
included in any PCR that would amplify the NatMX3 cassette. The components were
combined on ice and immediately placed at 95 C for five minutes to begin the reaction.
Forty cycles were carried out: 1 minute at 95 C, 1 minute at 54 C, and 3 minutes at 72
C. An additional seven minutes were added at 72 C for extension, followed by a hold at
4 C. Products were visualized by agarose gel electrophoresis. Southern blot analysis
was carried out as described in Chapter 1. PCR conditions to construct the DNA that
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Figure 2-1. Confirmation of a gene knock-out. After PTR3 was knocked-out
of FY2 with the cassette NatMX4, the knock-out was confirmed. The FY2 wild-type
control and four potential ptr3Δ strains were tested and shown below. A. The
NatMX4 cassette is 1.2 kb shorter than PTR3. Using primers flanking the knocked-out
region, PCR amplification yielded either a 2.9 kb fragment corresponding to PTR3, or a
1.7 kb fragment corresponding to the inserted cassette. Here, strain B was found to be
a false positive: it was incorrectly identified as a knock-out in the colony selection
process. B. Genomic DNA of each potential knock-out strain and wild-type was cut
with either FspI (F) or SacI (S), and separated by agarose gel electrophoresis; the lanes
were loaded equally. When the gel was probed with radiolabeled DNA corresponding
to a large part of PTR3 (nucleotides 35-1969), strain B was again shown to be a false
positive. Probe DNA hybridized to a 7.9 kb band when genomic DNA was cut with FspI
(F) and hybridized to 2.5 kb and 5.9 kb bands when DNA was cut with SacI (S),
demonstrating the presence of PTR3 in the wild-type control (FY2) and in strain B. The
strains labeled A, C, and D did not contain genomic DNA that hybridized to the probe;
strain A was used as the ptr3Δ strain in this study.
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was labeled for the probes were as follows: 2 units of RedTaq™ (Sigma-Aldrich; St.
Louis, MO), 1 pmol of each primer (Appendix 4), 200 µM dNTPs, 1x Sigma RedTaq
buffer with MgCl2, and 8 ng genomic DNA obtained as described in Chapter 1. The
components were combined on ice and immediately placed at 95 C for five minutes to
begin the reaction. Forty cycles were carried out: 1 minute at 95 C, 1 minute at 55 C,
and 3 minutes at 72 C. An additional seven minutes were added at 72 C for extension,
followed by a hold at 4 C.
Plasmid constructions containing a reporter gene.
In order to compare the relative amounts of transcript produced from a given
promoter under a defined set of conditions, a reporter gene is commonly used. The
gene, for example lacZ, is placed directly under the control of the promoter of interest.
This construct is most often introduced into a cell via a plasmid. Enzyme activity of the
reporter gene product is then measured in order to estimate transcript quantities. The
low-copy plasmid pYLZ6 (Appendix 3) contains lacZ and was constructed specifically for
the study of promoters by measurement of β-galactosidase activity in S. cerevisiae; it was
therefore chosen for this study.
The promoters of OPT1, OPT2, and YGL114W were cloned into pYLZ6 (Appendix 3)
by PCR amplification of 1 kb upstream of the ORF, including the start codon. Primers
(Appendix 4) were designed for homologous recombination into the plasmid, which had
been linearized at the HindIII site. PCR conditions to amplify the promoters were as
follows: 2 units of Pfu DNA polymerase (Stratagene; La Jolla, CA), 1 pmol of each
primer, 200 µM dNTPs, 1x buffer supplied with enzyme, 2.5 mM MgCl2, and 8 ng
genomic DNA. The components were combined on ice and immediately placed at 95 C
for five minutes to begin the reaction. Forty cycles were carried out: 45 seconds at 95
C, 45 seconds at 53 C, and 5 minutes at 72 C. An additional seven minutes were added
at 72 C for extension, followed by a hold at 4 C. The reaction was visualized by
separation of DNA on a 1% agarose/TAE gel with subsequent staining with ethidium
bromide. PCR products were purified by SOPE column (Open Biosystems). Each
product and the linearized plasmid were co-transformed into FY2 (Appendix 2) as
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described in Chapter 1. Plasmid was isolated from transformants and sequenced
(Appendix 4). These new plasmids were named pYLZ6-OPT1, pYLZ6-OPT2, and
pYLZ6-YGL114W after the gene whose promoter it contained.
Media and growth assays.
Synthetic complete (SC) medium was made using the original recipe for yeast
nitrogen base (Wickerham 1946; Wickerham 1951, Appendix 1). Modifications were
made to Wickerham’s medium to create media with reduced nutrients. Reduced
carbon medium contained 25% the amount of glucose as SC; reduced nitrogen medium
contained 10% the amount of ammonium sulfate, with the sulfate added back via sodium
sulfate; and reduced sulfur medium contained no ammonium sulfate and 10% the
amount of magnesium sulfate as SC, with the ammonium and magnesium added back via
the corresponding chloride salts. Reduced nitrogen and sulfur medium had no
ammonium sulfate and 10% of the magnesium sulfate that of SC; 10% the ammonium;
and 90% of magnesium added with their chloride salts. The full recipes may be found in
Appendix 1. To determine growth curves or gene expression levels in these media,
cells were first grown overnight in SC, harvested at top speed in a tabletop centrifuge,
and washed twice with cold water. These various media were then inoculated at 5 x
105 cell/mL.
β-galactosidase assays.
Assays for β-galactosidase activity were conducted using a protocol modified from
that of Hoffman et al. (2002). Cells containing the empty vector pYLZ6 or the vector
containing 1 kb upstream of the gene of interest (pYLZ6-OPT1, pYLZ6-OPT2, or
pYLZ6-YGL114W) were scraped from a fresh plate and grown overnight in 25 mL SC.
They were harvested in a tabletop centrifuge at high speed at 4 C, and washed three
times with cold water. Cells were inoculated into fresh media at 5 x 105 cells/mL and
grown for two to 12 hours. If amino acids were added, they were added simultaneously
with the cells, at concentrations required to fulfill auxotrophic requirements (Appendix
1). If GSH was added, it was at 250 µM. Aliquots were harvested as above for the
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growth assay. In a black 96-well plate, 100 µL of cells at 1 x 108 cells/mL were added to
each well. A fluorescein di-β-D-galactopyranoside (FDG; Molecular Probes/Invitrogen;
Eugene, OR) stock solution was made with 100 µM FDG in 25 mM PIPES (pH 7.2). The
stock solution was combined 1:1 with a 5% Triton X-100, 250 mM PIPES (pH 7.2)
solution; 20 µl of this final solution was added to each well. The 96-well plate was
incubated at 37 C in the dark for 4 hours. It was then read with a Victor2 Wallac
fluorescence multi-well plate reader (PerkinElmer; Gathersburg, MD) with an excitation
of 485 nm and an emission of 530 nm.
Leu-enkephalin uptake assays.
Cells containing the empty plasmid pYLZ6 were grown in SC or no sulfur medium
with or without amino acids or GSH as described for β-galactosidase assays. Uptake
assays were conducted over a 10-minute time period as described in Chapter 1.
Results
Determination of growth curves in media with limited and absent
nutrients.
Seven media variations were made: synthetic complete (SC; Wickerham’s yeast
nitrogen base with 2% glucose without amino acids), SC with reduced carbon, SC with
no carbon, SC with reduced nitrogen, SC with no nitrogen, SC with reduced sulfur, and
SC with no sulfur (Appendix 1). Each of the eight strains constructed, including wildtype, were grown in these seven media for up to 12 hours to determine log-phase
growth, with the inoculum being 5 x 105 cells/mL. Wild-type cells were in log-phase
between four and ten hours when grown in SC medium (Figure 2-2). After four hours,
growth of cells in media without a nitrogen source slowed compared to the growth of
cells in SC; the growth curves of cells without nitrogen and cells without nitrogen or
sulfur overlap (Figure 2-2.A). Growth of cells without sulfur slowed between eight and
ten hours, while cells grown with no carbon did not divide at all. There was no apparent
difference in growth curves between cells grown in SC and cells grown in any reduced
nutrient media. All deletion strains except for ygl114wΔ grew at the same rate as
38

Figure 2-2. Growth curves in reduced nutrient media and media
lacking nutrients. A. The strain FY2 was grown for up to 12 hours in SC, reduced
nitrogen (r N), no nitrogen (no N), reduced sulfur (r S), no sulfur (no S), reduced
nitrogen and reduced sulfur (r NS), no nitrogen or sulfur (no NS), reduced carbon (r C),
or no carbon media (no C). Cell density was measured every two hours. B. The
strains FY2 and ygl114wΔ were grown for up to 12 hours in SC, no sulfur (no S), or no
nitrogen (no N) media, and cell density was measured every two hours.
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wild-type (data not shown). When ygl114wΔ was grown in SC, its growth curve was
comparable to wild-type grown without nitrogen (Figure 2-2.B). Not only did ygl114wΔ
have limited growth, but also its colony and culture color was white in comparison to
wild-type S. cerevisiae, which was cream-colored. There was no visible microscopic
difference between ygl114wΔ and wild-type under growth conditions used in this study.
OPTp-lacZ expression under starvation conditions.
In order to create a reporter system, the lacZ ORF was placed under the control of
the promoter of OPT1, OPT2, or YGL114W; three plasmids were constructed. The
segment of DNA 1 kb upstream of the ORFs of OPT1, OPT2, and YGL114W, including
the start codon, was amplified and cloned into pYLZ6 (Appendix 3), immediately
upstream of the lacZ gene present in the plasmid. Cells of the wild-type strain FY2,
harboring pYLZ6-OPT1, pYLZ6-OPT2, or pYLZ6-YGL114W, were grown for up to 12
hours in each of the seven media. Cells were harvested every two hours and tested for
β-galactosidase activity. Background was determined using FY2 transformed with the
empty vector pYLZ6 grown in SC.
Cells containing pYLZ6-OPT1 grown without sulfur showed increased βgalactosidase activity by six hours (Figure 2-3). Cells containing either pYLZ6-OPT2 or
pYLZ6-YGL114W did not show any increased activity when grown in these media when
compared to when grown in SC (data not shown).
OPT1p-lacZ expression in the presence of amino acids.
Since OPT1 expression increased when cells were grown without sulfur, the study of
OPT1 expression was extended. Because the cell growth slowed after eight hours when
cells were grown with no sulfur, cells of the strain FY2 bearing pYLZ6-OPT1 were
grown for up to eight hours in either SC or no sulfur media containing leucine, proline,
or no added amino acids. Cells were harvested every two hours and assessed for βgalactosidase activity (Figure 2-4). As seen in Figure 2-3, no sulfur medium induced
OPT1 expression by the six-hour time point. Proline and leucine both increased
expression of OPT1; the highest induction of leucine was at the six-hour time point
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Figure 2-3. Sulfur-free medium induces OPT1 expression. Wild-type cells
(FY2) harboring pYLZ6-OPT1, pYLZ6-OPT2, or pYLZ6-YGL114W were grown in SC
medium. Additionally, cells containing pYLZ6-OPT1 were grown in medium lacking
sulfur. Aliquots were taken every two hours for 12 hours and assayed for βgalactosidase activity. β-galactosidase activity was reported as relative fluorescence.
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Figure 2-4. Time course of OPT1 induction by amino acids. Wild-type
cells (FY2) harboring pYLZ6-OPT1 were grown in SC (+ on abscissa) or no sulfur
medium (- on abscissa) with leucine (grey bars) or proline (checkered bars), or without
supplemented amino acid (open bars). Aliquots were taken every two hours for eight
hours, and β-galactosidase activity was measured. β-galactosidase activity was reported
as relative fluorescence.
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while proline’s induction was more constant over the course of the experiment,
inducing best between four and six hours. From these results, the six-hour time point
was chosen for all further experiments.
The induction of OPT1p-lacZ was then assayed after growth in SC and no sulfur
media with each of the twenty naturally occurring amino acids individually present
(Figure 2-5). While leucine and tryptophan were the best inducers of OPT1 when cells
were grown in SC, they were not the best inducers when cells were grown without
sulfur in the medium. Unlike leucine, most amino acids seemed to have a synergistic
effect on OPT1 expression when combined with no sulfur medium. The acidic amino
acids — aspartic acid and glutamic acid — followed by tyrosine, were the best inducers
of OPT1 when added to medium lacking sulfur. The sulfur-containing amino acids,
cysteine and methionine, did not induce OPT1 even when all other sulfur was removed
from the medium; methionine even down-regulated OPT1 in both SC and no sulfur
media.
OPT1p-lacZ expression in deletion strains.
Because both Ptr3p and Ssy1p are known to induce gene expression of amino acid
and di/tri-peptide transporters by sensing leucine and tryptophan, it was hypothesized
that these proteins were also involved in the regulation of the gene encoding the
oligopeptide transporter Opt1p. Additionally, it was hypothesized that the presence or
absence of the other gene encoding the other oligopeptide transporter in S. cerevisiae,
OPT2, also affected OPT1 expression. If Opt2p is not present, perhaps the yeast cell is
able to recognize that fewer oligopeptide transporters are present and the transcription
of available OPTs is stepped up to compensate for this deficiency. Likewise, the cell may
be capable of detecting the lack of Opt1p itself, and attempt to up-regulate OPT1 in its
absence. To test these hypotheses, gene knock-out strains that were constructed in the
FY2 background (Appendix 2) containing pYLZ6-OPT1 (Appendix 3) were assayed for
β-galactosidase activity. Cells of the knock-out strains opt1Δ, opt2Δ, ptr3Δ, ssy1Δ, ptr3Δ
ssy1Δ, and ptr3Δ opt1Δ and the wild-type strain FY2 were transformed with pYLZ6OPT1 and grown in the presence and the absence of several of the naturally occurring
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Figure 2-5. Amino acids modulate OPT1 expression. Wild-type cells (FY2)
bearing pYLZ6-OPT1 were grown for six hours in SC (grey bars) or no sulfur medium
(black bars) without supplemented amino acids (none) or with each amino acid added,
indicated by one-letter abbreviations. β-galactosidase activity is represented as a ratio
of fluorescence compared to FY2 grown in SC without amino acids: the relative
fluorescence was calculated by dividing the fluorescence of β-galactosidase activity in the
experimental sample by the fluorescence of β-galactosidase activity produced in the
strain FY2 grown in SC medium without amino acids.
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amino acids or GSH (γ-Glu-Cys-Gly) for six hours. These strains were then assayed for
β-galactosidase activity (Figure 2-6).
When knock-out strains were grown in either SC or no sulfur medium
supplemented with leucine, OPT1 expression in the strains with the single gene
knockouts of opt1Δ and opt2Δ responded to leucine comparably to wild-type (Figure 26.A). OPT1 expression in strains containing deletions of ptr3 and ssy1, however, was not
up-regulated in the presence of leucine. The effect of these gene knock-outs are similar
when cells were grown in either SC or no sulfur media without any addition of amino
acids.
When the sulfur-containing amino acids, methionine and cysteine, were
supplemented to SC or no sulfur medium, OPT1 was not up-regulated in any of the
deletion mutants or in wild-type cells (Figure 2.6.B). It is likely that these amino acids
supply the cell with enough sulfur as to not require the up-regulation of OPT1. Similarly,
the effect of no sulfur medium is not seen when it is supplemented with GSH. The only
strain to retain the up-regulation of OPT1 in this instance is opt1Δ. Since the gene
encoding the GSH transporter is absent, the cell is not able to take up the sulfur
supplied by the GSH, and thus OPT1p-lacZ is up-regulated since it is obtaining no sulfur
from its environment (Figure 2-6.B).
The effect of PTR3, SSY1, OPT1, and OPT2 on the expression of OPT1p-lacZ was also
examined in the presence of the inducing amino acids aspartic acid, glutamic acid, and
tyrosine (Figure 2-6.C). Similar to results observed upon the addition of leucine (Figure
2-6.A), the absence of PTR3 and SSY1 eliminated the induction of OPT1 in the presence
of the acidic amino acids and tyrosine when cells were grown in sulfur-free medium.
Unlike induction by leucine, the absence of OPT1 and OPT2 affected OPT1p-lacZ
expression when cells grown without sulfur were supplemented with aspartic acid,
glutamic acid or tyrosine (Figure 2-6.C). Without OPT1 or OPT2, OPT1p-lacZ expression
is reduced by almost half with the addition of aspartic acid, as is OPT1p-lacZ expression
when opt1Δ cells are supplemented with glutamic acid. OPT1 is not induced in opt2Δ
cells, however, when glutamic acid is added. When either OPT is knocked-out,
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Figure 2-6. OPT1 induction is dependent on PTR3, SSY1, and OPT2.
Wild-type cells (FY2) and the deletion mutant strains opt1Δ, opt2Δ, ptr3Δ, ssy1Δ, ptr3Δ
ssy1Δ, and ptr3Δ opt1Δ harboring pYLZ6-OPT1 were grown for six hours in SC or no
sulfur medium with or without leucine (A); methionine, cysteine, or GSH (B); or
aspartic acid, glutamic acid, or tyrosine (C). β-galactosidase activity is represented as
the ratio of fluorescence compared to the fluorescence of FY2 grown in SC without
amino acids: the relative fluorescence was calculated by dividing the fluorescence of βgalactosidase activity in the experimental sample by the fluorescence of β-galactosidase
activity produced in the strain FY2 grown in SC medium without additions. For clarity,
panels A, B, and C have different ordinate scales, and the values for no additions are
repeated in each panel.
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OPT1p-lacZ expression is reduced by more than half when sulfur free medium is
supplemented with tyrosine.
The effect of the ORF YGL114W, although not likely an oligopeptide transporter,
was also investigated as to its potential role in OPT1 expression. Because ygl114wΔ cells
grew poorly even in SC (Figure 2-2.B), the yield of cells from 2 L of primary culture was
only enough to investigate YGL114W’s effect on OPT1p-lacZ expression in SC and
medium lacking sulfur, each with or without leucine or cysteine. Under all six medium
conditions, these cells showed OPT1 expression that was barely above background
levels. Thus, the result of the influence of YGL114W on expression of OPT1 could not
be calculated with this strain.
Leu-enkephalin uptake under variant nutrient conditions.
Since the β-galactosidase assay only measured expression levels of OPT1, a functional
assay for Opt1p was used to complement the gene expression data. Leu-enkephalin
uptake was measured, thereby assessing the functionality of Opt1p. Cells grown under
the same conditions used in the lacZ study were assayed for their ability to accumulate
[3H]-Leu-enkephalin over ten minutes (Figure 2-7). FY2 cells harboring the empty
vector pYLZ6 were grown in either SC or no sulfur medium with or without amino
acids and GSH (Figure 2-7.A). Consistent with the lacZ assay results, growth in sulfurfree medium with the addition of aspartic acid, glutamic acid, or tyrosine increased the
cells’ ability to transport Leu-enkephalin. Growth with the addition of either cysteine or
GSH did not increase Leu-enkephalin uptake, and the addition of methionine reduced
transport of the pentapeptide to half of that observed in FY2 cells grown in SC. Leucine
increased the transport capability of FY2 when grown without sulfur, but did not
increase transport when cells had been grown in SC supplemented with leucine, even
though β-galactosidase activity suggested leucine increased OPT1 expression in this
medium.
When opt2Δ cells were tested for their ability to accumulate [3H]-Leu-enkephalin,
results were consistent with those of the lacZ assay: compared to FY2, uptake of
substrate was reduced when aspartic acid was supplemented and similar to
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Figure 2-7. [3H]-Leu-enkephalin uptake. Cells were grown for six hours
with or without sulfur, the media supplemented with various amino acids, GSH, or
nothing. To be consistent with the media used in the lacZ assays, all cells harbored the
vector pYLZ6. Cells were incubated for ten minutes with 250 µM [3H]-Leu-enkephalin.
Uptake is represented as the accumulation of nmol [3H]-Leu-enkephalin per milligram of
cells (dry weight). A. Accumulation of Leu-enkephalin in the wild-type strain FY2 after
growth in either SC or sulfur-free medium supplemented with methionine, cysteine, or
GSH. B. Accumulation of Leu-enkephalin in FY2 after growth in either SC or sulfurfree medium and in opt2Δ after growth in sulfur-free medium. These media were
supplemented with leucine, aspartic acid, glutamic acid, tyrosine, or nothing. C.
Accumulation of Leu-enkephalin in FY2, opt2Δ, ptr3Δ, ssy1Δ, and opt1Δ after growth in
medium lacking sulfur supplemented with leucine. Also included is the control of FY2
grown in SC with leucine added.
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unsupplemented SC when tyrosine was added (Figure 2-7.B). The effect of the absence
of PTR3, SSY1, and OPT1 on Leu-enkephalin uptake was tested after cells were grown
without sulfur and supplemented with leucine (Figure 2-7.C). As expected, leucine did
not lead to increased uptake in ptr3Δ or ssy1Δ cells. The opt1Δ strain showed no
transport of Leu-enkephalin.
Taken together with the results of the β-galactosidase assays, these data yield a set
of environmental conditions that govern the expression profile of OPT1.
Discussion
Little is known about the transcriptional regulation of the OPT genes in S. cerevisiae,
but some evidence is available regarding native conditions for transcription for members
of the OPT family in other species (Hauser et al. 2001). Isp4p from S. pombe was initially
identified in a screen to find factors in mating, induced by poor nitrogen (Sato et al.
1994), but later found to be up-regulated by use of proline as the sole source of
nitrogen (Lubkowitz et al. 1998). Although this regulation is most likely transcriptional,
the up-regulation was demonstrated by the ability of cells to grow on peptide as the
sole source of a required amino acid.
Here we show that absence of sulfur in the medium up-regulates expression of
OPT1. Boer et al. (Boer et al. 2003) found similar results in microarray studies in
chemostat cultures grown with limited sulfur. Unlike Boer et al., however, we observed
no change in OPT1 expression in the absence of carbon for up to ten hours — they
observed the down-regulation of OPT1 under conditions limiting carbon. Gasch et al.
(2000) detected a great increase in OPT1 expression by microarray analysis when cells
were depleted of nitrogen, yet our study as well as that of Boer et al. did not see this
result. PTR2, the gene encoding the di/tri-peptide transporter in S. cerevisiae, is also
regulated by limited nutrient conditions. The gene is up-regulated when cells are grown
in a poor nitrogen source (Perry et al. 1994). Ptr2p’s substrate is similar to Opt1p’s, but
perhaps physiologically they are more different than initially thought. Ptr2p is likely
present to scavenge amino acids as a nitrogen source whereas Opt1p’s primary function
may be to obtain sulfur for the cell, namely in the form of glutathione.
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Our data indicate that OPT1 is differentially regulated by various amino acids when
starved for sulfur. Of the twenty naturally occurring amino acids, the acidic amino acids
— aspartic acid and glutamic acid — up-regulate OPT1 to the greatest degree, followed
by tyrosine. The only amino acids not to up-regulate OPT1 expression in sulfur-free
medium are the two containing sulfur, cysteine and methionine. Additionally,
glutathione does not up-regulate OPT1. It is likely that when these compounds are
transported into the cell, they supply it with enough sulfur to negate the effect of the
sulfur-free medium. When opt1Δ cells are grown in medium lacking sulfur that has been
supplemented with glutathione, OPT1p-lacZ expression is up-regulated to the same
extent as if it were grown in sulfur-free medium without any additions. This suggests
that with no Opt1p expression, no GSH was able to enter the cell, and the condition
therefore simulated a no sulfur medium. Unlike cysteine and glutathione, however,
methionine down-regulates OPT1. One untested hypothesis explaining this is that in the
wild, the presence of certain amino acids indicates to the cell that certain peptides are
available for scavenging. Another is that no sulfur in the medium signals the cell that
there is a lack of, or at least very few, amino acids, but the presence of methionine in
the environment is a signal to the cell that there is enough sulfur and therefore there
are enough amino acids being taken into the cell and so OPT1 is down-regulated.
When cells were grown in SC and an amino acid, leucine and tryptophan upregulated OPT1 the most when compared to other amino acids. This is similar to PTR2
and BAP2 induction — leucine and tryptophan are the best inducers (Didion et al. 1998)
— but OPT1 expression is not increased as much by these amino acids as PTR2 is. PTR2
is up-regulated 100-fold upon the addition of tryptophan or leucine (Narita 2002),
whereas OPT1 is up-regulated about 10-fold. Leucine and tryptophan induce OPT1 when
cells are grown without sulfur, but only moderately when compared to the other amino
acids.
The amino acid sensor Ssy1p and its associated protein Ptr3p are responsible for the
regulation of genes encoding amino acid transporters and the regulation of PTR2. The
SPS system responds to leucine and tryptophan (Didion et al. 1998) and is able to sense
all other amino acids except proline and arginine in assays measuring AGP1p-lacZ
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expression (Iraqui et al. 1999). Here we show that both SSY1 and PTR3 are required for
induction of OPT1. A microarray study investigating the effects of the SPS sensor system
responding to leucine found less than a two-fold change in OPT1 expression, but the
medium in which the cells were grown was SC (Forsberg et al. 2001).
No difference was seen in either OPT2 or YGL114W expression when cells were
grown without various nutrients as compared to when grown in SC. They are
therefore induced by different conditions than those tested in this study. There must be
a different physiological state in which Opt2p is the preferred oligopeptide transporter.
Perhaps its favored substrate is something other than a peptide. It may be that Opt2p
transports a variety of biological molecules in the same manner that Opt1p transports
glutathione with better affinity than Leu-enkephalin (Chapter 1) and Ptr2p is able to
transport β-lactams (Meredith and Boyd 2000).
Few studies have been conducted on genes expressed under sulfur-starvation. For
the first time, direct evidence is shown that OPT1 and Opt1p expression is dependent
on the sulfur content of the medium. Additionally, we show for the first time, evidence
that expression is induced by all but the sulfur-containing amino acids and that
expression is dependent upon the presence of PTR3 and SSY1. This extends the roles of
Ptr3p and Ssy1p to regulation of all peptide and amino acid permeases in yeast.

53

Chapter 3
Search for a gene encoding a mammalian enkephalin
transporter.
Background and Significance
We have identified a permease family with members from a number of fungi and
plants that transports tetra- and pentapeptides (Hauser et al. 2001; Koh et al. 2002)
Chapter 1). A Saccharomyces cerevisiae member, Opt1p, transports the pentapeptides
Leu-enkephalin (YGGFL) and Met-enkephalin (YGGFM) (Hauser et al. 2000; Chapter 1).
The enkephalins are in a class of compounds known as the endorphins (for endogenous
morphine), which are potent analgesics found exclusively in mammals (Goldstein 1976).
Although the physiological effects of the endorphins, including the enkephalins, have
been well-studied, the molecular mechanisms of the molecules are less well understood.
The role of enkephalins in mammalian brain.
A group of G-protein coupled receptors, known as opioid receptors, is found in
mammalian brain and cause analgesia. The three types of opioid receptors are µ, κ, and
δ (Pasternak 2004). The enkephalins, both Leu- and Met-enkephalin, were first
identified as agonists of the µ-opioid receptors, inhibitors of the exogenous antagonist
naloxone (Hughes et al. 1975; Simantov and Snyder 1976). They were soon after
determined to be neurotransmitters, along with the other endorphins dynorphin and βendorphin (Nicoll et al. 1977). Of the endorphins, the two enkephalins are by far the
most effective at producing effects down-stream of receptor binding, specifically a
decreased perception of pain and an increase in eating and drinking (Miller). The binding
of the enkephalins to µ-opioid receptors can be inhibited by the agonists tyrosine-Dpenicillamide-glycine-phenylalanine-D-penicillamide ([D-penicillamide2,5]enkephalin;
DPDPE), D-Ala,D-Leu-enkephalin (Tyr-D-Ala-Gly-Phe-D-Leu; DADLE), and morphine; by
the antagonists naloxone and naltrexone (Pasternak 2004); and by the endogenous
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antiopiate tetrapeptide Tyrosine Melanocyte-stimulating Hormone Inhibitory Factor 1
(Tyr-MIF-1; Tyr-Pro-Leu-Gly-NH2).
The µ-opioid receptor agonist morphine was the first opioid identified and has long
been used as an analgesic due to its long retention time in the brain (see Nestler 1992
for review). Morphine’s endogenous role in the opium poppy Papaver somniferum is that
of an early mechanical defense mechanism (Morimoto et al. 2001; Morimoto et al. 2003),
a entirely different function than what it accomplishes in the mammalian brain. The µopioid receptor antagonists naloxone and naltrexone have been used to not only inhibit
the binding of opioids (Pasternak 2004) but also to reduce the cravings for those opioids
in individuals who are addicted to them (Schulteis et al. 2003). Additionally, these
antagonists have a pharmacological role in treating alcoholism by reducing volition
ethanol drinking (Pulvirenti and Kastin 1988; Volpicelli et al. 1992). Agonists of µ-opioid
receptors do not have this effect (Pulvirenti and Kastin 1988)
Transport of the enkephalins across the blood-brain barrier.
Because the enkephalins are synthesized in the adrenal medulla (Wilson et al. 1980),
yet have their primary action at opioid receptors in the brain, there must be some
relatively efficient mechanism of transporting enkephalins across the blood-brain barrier
(BBB) in order to access their receptors. This transport had been observed in mice and
rats (Cornford et al. 1978; Rapoport et al. 1980), and finally a saturable uptake system
was identified by physiological criteria (Banks et al. 1986) and named peptide transport
system 1 (PTS-1) (Banks and Kastin 1990). Observations of a similar nature were made
for the uptake of Tyr-MIF-1 (Banks et al. 1986), and it was later determined that the
enkephalins and Tyr-MIF-1 share PTS-1 for transport across the BBB (Banks et al. 1987;
Banks and Kastin). It has been observed that Leu-enkephalin, however, may use more
than one transport system to cross the BBB (Banks and Kastin 1989; Zlokovic et al.
1989).
Enkephalin uptake into the brain is inhibited by the µ-opioid receptor ligands
naloxone, naltrexone, morphine, and DADLE (Kastin et al. 1991; Williams et al. 1996).
Straight chain peptides composed of four to eight residues inhibit substrate
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translocation by PTS-1, as long as the N-terminal residue is an L-tyrosine (Banks et al.
1986). Neither di/tri-peptide N-terminal truncations of Tyr-MIF-1 or enkephalin nor
the amino acid tyrosine can inhibit substrate transport by PTS-1 (Banks et al. 1986;
Zlokovic et al. 1989).
In addition to enkephalins, it has been found that reduced glutathione (GSH) is able
to traverse the BBB. An intensive study determined that GSH is not synthesized in the
brain from free amino acids but is rather transported into the brain (Zlokovic et al.
1994). Additionally, there are two transport mechanisms present to transport GSH
into the liver (Ballatori and Dutczak 1994). Neither of these two transport systems are
ATP-dependent but are electrogenic. Evidence also exists for a hepatic enkephalin
transporter; this uptake of Leu-enkephalin is inhibited by naloxone (MacKinnon et al.
1994). Even though GSH and enkephalin are both transported into the brain and into
the liver, no literature exists directly comparing the uptake of the two substrates.
Researchers have begun to search for the permease that is PTS-1. The Pglycoprotein efflux system (P-gp system) was investigated as such. Although it was
shown that the P-gp system is responsible for transport of some µ-opioid receptor
inhibitors, it is not required for enkephalin or Tyr-MIF-1 efflux (King et al. 2001). We
have investigated Opt1p for the possibility that it shares the function and transport
characteristics of PTS-1. We also set out to discover an OPT family member, or
possibly a functional analog, in rat. At the time this study was begun, there had been
neither any BBB peptide transporter cloned nor any mammalian genome fully
sequenced.
Materials and Methods
Competitive uptake assays.
The strain BY4730 (Appendix 2), transformed with either pDB20 or pADH212c
(Appendix 3), was grown to mid-logarithmic phase in poor nitrogen medium with
methionine and leucine added for auxotrophic requirements (Appendix 1). Uptake
assays were conducted as described in Chapter 1, with either 250 µM [3H]-Leuenkephalin for cells constitutively expressing OPT1 or 160 µM [3H]-leucyl-leucine (Leu56

Leu; dileucine) for cells induced with tryptophan to express PTR2, over a 12-minute time
period. Potential competitors of peptide transport were added simultaneously with the
radiolabeled peptide (all competitors were purchased from Sigma; St. Louis, MO). In
experiments measuring inhibition of [3H]-Leu-enkephalin transport, 2.5 mM Metenkephalin, MIF-1, Tyr-MIF-1, Leu-enkephalin amine, DPDPE, DADLE, or morphine
sulfate was present in the uptake medium (Chapter 1). The concentration of naloxone
was 9 mM and naltrexone was 15 mM in 1.25% methanol. Ethanol concentration was at
3% w/v.
Southern blot analysis of mouse genomic DNA.
Mouse genomic DNA (a generous gift from Amy Inselman, Mary Ann Handel’s lab)
was probed for the presence of a member of the OPT family. Southern blot analysis
was performed as described in Chapter 1, and the wild-type strain FY2 (Appendix 2)
was used as a positive control. DNA was cut with the restriction enzymes HindIII and
BamHI. The blot was probed with OPT1 and degenerate primers designed at
CODEHOP (Appendix 4).
Library amplification in E. coli.
The rat whole-brain cDNA library (pVT102Ulib) in the yeast vector pVT102U
(Appendix 3) was a kind gift from Pietro De Camilli’s lab (Yale University, CT). The
library contained 2 x 106 individual recombinants and was constructed with all inserts to
be larger than 500 bp; over 90% of the library contained inserts, the average size being
1.5 kb (Maggie Butler, personal communication).
pVT102Ulib was electroporated into DH5αE electro-competent cells (Invitrogen;
Carlsbad, CA) using a MicroPulser (Bio-Rad; Hercules, CA) set on Ec1 (0.1 cm cuvette,
1.8 kV, 1 pulse). Two independent electroporations were carried out, each with 45 µL
of DH5αE cells and 100 ng/µL pVT102Ulib in a final volume of 46 µL. Immediately after
electroporation, 1 mL ice-cold LB (Appendix 1) was added, and the cells were allowed
to recover for 1 hour at 37 C while shaking at 225 rpm. Aliquots of 50 µL of recovered
cells in a total volume of 1 mL were spread onto 600 cm2 plates (Corning; Acton, MA)
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containing LB +Amp (Appendix 1). Plating was chosen over liquid culture to enrich for
lower copy number clones. Colonies were grown overnight at 37 C. The cells on each
of the 40 plates were scraped three times into LB with a sterile glass spreader and the
suspension was pipetted off. Cells were pelleted, and plasmid DNA was isolated using a
total of four Wizard Plus Megaprep columns (Promega; Madison, WI). The
transformation efficiency averaged 1.95 x 108 (2 replicates: 1.8 x 108 and 2.1 x 108)
CFU/µg and the plasmid preparation yielded an average of139 (3 replicates: 175, 128,
113) ng/µL DNA at an A260/280 of 1.7 (3 replicates: 1.82, 1.62, 1.59) with a total amount
of 832 µg of amplified pVT102Ulib.
Transformation of cDNA library into S. cerevisiae.
Four large scale, high-efficiency yeast transformations were done for each screen
using a lithium acetate method modified from the standard Geitz lab method (Agatep et
al. 1998). The transformations were carried out in 15 mL Falcon tubes (BD Biosciences;
San Jose, CA) with 25 µg amplified pVT102Ulib per tube. The optimum heat shock time
for the strain used, BY4742 opt1Δ (Appendix 2), was determined to be 20 minutes at 42
C. A small aliquot of each reaction was used to calculate the transformation efficiency.
Using sterile glass beads, the remainder was plated onto 600 cm2 bioassay dishes
(Corning) containing casamino acid medium (Appendix 1); the transformation efficiency
was 1.1 x 105 CFU/µg DNA.
Functional augmentation growth screen and analysis.
The screens for the ability of cells transformed with a plasmid from the cDNA
library to grow on peptide as the sole source of a required amino acid immediately
followed their transformation (Figure 3-1). After 72 hours of growth, transformed cells
were scraped off the plates with a sterile glass spreader and 30 mL sterile water. Cells
were then pelleted and pooled, and 2 x 107 cells were plated on poor nitrogen medium
(Appendix 1) with histidine and either lysine (screen 1) or leucine (screen 2) to fulfill
auxotrophic requirements. Additionally, plates used in screen 1 were supplemented
with no leucine, leucine, YGGFL, KLLG, or KLLLG to fulfill the strain’s leucine
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Figure 3-1. Diagram of functional augmentation strategy. Two screens
were conducted to find a mammalian oligopeptide transporter by functional
augmentation. The initial round of the first screen required cells to grow on peptide as
the sole source of leucine, whereas the second screen required them to grown on
peptide as the sole source of lysine.
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requirement; plates used in screen 2 contained no lysine, lysine, KLLG, or KLLLG for
the strains lysine requirement. Peptide concentrations were 300 µM and calculated to
provide the cell with a molarity of leucine or lysine similar to that of the free amino acid
provided in the control plates.
Colonies that grew on peptide as the sole source of either leucine or lysine were
streaked for isolation on medium corresponding to the medium on which they grew in
the screen. Plasmids from three isolates from each colony were recovered and
subjected to restriction digest by XhoI to check for an insert, and one plasmid copy
from each colony was sequenced (Appendix 4; Sanger et al. 1977). Meanwhile, each
plasmid was retransformed into BY4742 opt1Δ as described in Chapter 1 and tested for
growth on YGGFL, KLLG, and KLLLG as the sole source of leucine or lysine. (The
strain used, BY4742 opt1Δ, was first tested to make certain it could not grown on media
containing YGGFL, KLLG, or KLLLG as sole sources of leucine or lysine.)
Results
Inhibitors of PTS-1 also inhibit Opt1p.
Competition uptake assays with S. cerevisiae strain BY4730 (Appendix 2) containing
pADH212C (Appendix 3) over-expressing OPT1 were performed measuring the
translocation of [3H]Leu-enkephalin in the presence of various small peptides, peptide
analogs, and ligands of the mammalian enkephalin receptor (Figure 3-2.A). As with PTS1 (Banks et al. 1986), the tripeptide MIF-1 does not compete for uptake of enkephalin by
Opt1p, but inhibition was seen with other tetra- and pentapeptides present in the
uptake medium, such as Met-enkephalin, TMIF-1, DPDPE, and DADLE. The opioid
receptor agonist morphine and antagonists naloxone and naltrexone all inhibited Leuenkephalin uptake by Opt1p in S. cerevisiae.
The transport capabilities of Ptr2p were employed to demonstrate that the nonpeptide-based analogs naloxone and naltrexone were specifically inhibitors of Leuenkephalin transport by Opt1p and not general permease inhibitors or disrupters of
cellular stability (Figure 3-2.B). [3H]-dileucine uptake was measured in the presence of
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Figure 3-2. Peptide uptake by yeast in the presence of inhibitors of
PTS-1 transport. Substrate and competitors were added simultaneously at time
zero, and transport was measured in quadruplicate over a 12-minute period at 30 C.
Each competitor is reported as percentage of substrate transported as compared to
control. A. [3H]-Leu-enkephalin uptake was measured at a final concentration of 250
µM. Concentration of competitors were: 9 mM naloxone, 15 mM naltrexone, 3%
ethanol, and 2.5 mM for all others. B. [3H]-dileucine uptake was measured at a final
concentration of 160 µM. Concentrations of competitors were: 9 mM naloxone, 15
mM naltrexone, and 3% ethanol.
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naloxone and naltrexone, and it was found that these compounds did not inhibit
dileucine uptake as they did Leu-enkephalin.
In mammalian model systems, addiction to alcohol inhibits uptake of the enkephalins
into the brain by PTS-1 (Plotkin et al. 1997). When ethanol was added to the uptake
medium, inhibition of Leu-enkephalin transport was seen (Figure 3-2.A); when the effect
of ethanol on the transport of dileucine by Ptr2p was measured, however, similar results
were observed (Figure 3-2.B), suggesting that this effect is not specific to transport by
Opt1p.
Techniques employed to find homologous OPT sequences in mouse
yielded no members.
Seven primers were constructed with a mouse-codon bias from highly conserved
regions submitted to the algorithm Consensus-degenerate Hybrid Oligonulecotide
Primers (CODEHOP; bioinformatics.weizmann.ac.il/blocks/codehop.html). All twelve
primer combinations were used in attempt to amplify a sequence bearing some similarity
to the OPT family — specifically with similarity to the highly conserved regions found by
BLOCKS (bioinformatics.weizmann.ac.il/blocks/). Unfortunately, no PCR products were
observed (data not shown).
Genomic Southern blot analysis was also attempted to visualize potential OPT family
members in mouse. Genomic DNA prepared from the wild-type S. cerevisiae strain FY2
was used as a control; genomic DNA from mouse was probed with OPT1 from S.
cerevisiae. As with the PCR method discussed above, no positive results for a potential
murine OPT were observed (Figure 3-3).
Functional augmentation screen of a rat brain cDNA library expressed
in yeast revealed no oligopeptide transporter.
In order to validate the selection process, a background of leu- cells was mixed with
107 times fewer leu+ cells and spread in a lawn on plates lacking leucine. This was done
in three concentrations: 107, 108, and 109 leu- cells with 1, 10, and 100 leu+ cells,
respectively. Two, 12, and 96 leu+ colonies were observed, therefore cell background
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Figure 3-3. No mouse homologues are found by Southern blot
analysis. S. cerevisiae (FY2, control) and mouse genomic DNA was digested with
HindIII or BamHI and separated by gel electrophoresis. The subsequent Southern blot
hybridization with OPT1 yielded two expected bands in the FY2 lane, but no positives
were seen in the lanes containing mouse genomic DNA.
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up to 109 cells per plate neither interferes with growth of leu+ colonies nor does the
large cell mass allow non-leu- cells to propagate.
Two independent functional augmentation screens were attempted. Both involved
plating cells of strain BY4742 opt1Δ that had been transformed with the rat brain cDNA
library in pVT102U onto media selective for growth on peptides as a sole source of the
appropriate amino acid (Figure 3-1). In the first functional augmentation screen, cells
transformed with the library were plated on each of the following: medium containing
YGGFL, KLLG, or KLLLG as the sole source of leucine and the controls of no leucine
and free leucine. In order to ensure the integrity of the media, an aliquot of each
medium was poured as a small plate on which cells transformed with OPT1 or CaOPT1
expressed from the ADH promoter or empty vector were spotted (Appendix 3).
Unfortunately, there appeared to be a gene in the library that complimented the leu2
auxotrophy of the cells. Perhaps this was caused by another plasmid contaminating the
library or even accidentally partially used in library creation since there is a sibling
plasmid that bears LEU2 instead of URA3 as a selectable marker. Regardless of the
reason, the screen for cells bearing plasmids encoding peptide transporters that can
grow on leucine-containing peptides as the sole source of the amino acid was unreliable,
so another method needed to be performed.
A second screen was therefore set up that relied on the ability of transformed cells
to survive on a lysine-containing peptide as the sole source of that amino acid; this
meant that Leu-enkephalin could not be used. In this second screen, transformed cells
were plated on medium containing either KLLG or KLLLG as the sole source of lysine
and on the control media with or without free lysine. No cells were observed on
medium with no added lysine, and a lawn of cells was seen on medium containing free
lysine. In addition, 40 colonies grew on medium containing KLLLG after a period of
three days. No colonies were seen on the medium containing KLLG. All observed
colonies were streaked for isolation on medium with KLLLG as the only source of
lysine. Plasmids from these isolates were purified and sequenced. No plasmids that
were isolated in this manner contained an ORF, and when tested again for growth on
YGGFL, KLLF, or KLLLG as the sole source of either leucine or lysine, no colonies that
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contained one of these plasmids grew, thus all 40 of the colonies isolated in this screen
were false positives.
Discussion
Opt1p, a yeast member of the Oligopeptide Transporter family, was discovered to
transport the pentapeptides Met- and Leu-enkephalin — two endogenous, mammalian
opioids — and glutathione (Chapter 1; Bourbouloux et al. 2000; Hauser et al. 2000).
We have also determined that the transport of Leu-enkephalin by Opt1p is inhibited by
peptides and other compounds that also inhibit PTS-1 in murine brain (Banks et al.
1986). Furthermore, we found that free amino acids and degradation products of Leuenkephalin up to tripeptide fragments did not inhibit substrate transport by Opt1p, just
as it had been observed that fragments of the substrates Tyr-MIF-1 (Banks et al. 1986)
and the enkephalins (Zlokovic et al. 1989) did not inhibit enkephalin transport by murine
PTS-1.
We found that Tyr-MIF-1 only inhibited uptake of Leu-enkephalin 22% when present
at ten-fold the molarity of Leu-enkephalin, yet it has been noted that for rat PTS-1,
which transports Tyr-MIF-1 across the BBB, has a higher affinity for Met-enkephalin than
for Tyr-MIF-1 (Banks et al. 1986). Morphine, naloxone, naltrexone, DPDPE, and DADLE
also inhibited the uptake of Leu-enkephalin into the yeast cell by Opt1p. This, of course,
has been demonstrated to be true of PTS-1 by many authors (Banks and Kastin 1990).
We know the inhibition by naloxone and naltrexone is specific for transport by Opt1p
since dileucine transport by Ptr2p in yeast in unaffected by these molecules. Other
observations from our lab indicate that Opt1p also transports [3H]naloxone (Hauser,
Becker, unpublished data). Ethanol inhibits Leu-enkephalin uptake at just 3% and
eliminates uptake at 10% (data not shown) during a 12-minute assay. This inhibition is
not specific: ethanol inhibits dileucine transport by Ptr2p equally well.
Because S. cerevisiae Opt1p had shown remarkable functional similarities to the
mammalian BBB transport system PTS-1, it was hypothesized that an OPT family
member could be responsible for the effects of PTS-1. No homologues were found,
however, by searching various animal databases for sequence similarity (Chapter 1) nor
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was a homologue found by probing mouse genomic DNA by Southern blot analysis or
by PCR with degenerate primers in OPT regions of high homology (data not shown).
Because no animal genomes had yet been fully sequenced when this endeavor was
launched, we set out to screen a rat brain cDNA library, expressed in yeast, by
functional augmentation, in order to find a mammalian protein that functioned as an
OPT. Although the library was screened with 10-fold redundancy, no such protein was
found.
There were several issues involved in the functional augmentation screen which,
when taken together, may account for its lack of success. First, the library had not been
created unidirectionally (Burton et al. 1993), making it necessary to screen twice as
many clones. It also had not been constructed to enrich for low-copy transcripts, and it
had been created from whole adult rat brain. Since we were looking for a membrane
transporter presumably found exclusively at the BBB, the construction of this cDNA
library was not optimum for our needs. Second, since it was necessary to screen so
many clones, the cost of peptide required to plate only 105 cells per plate was
prohibitive; instead, 2 x 107 cells were screened per plate. Complications with the
ability of leu- cells transformed with the library to grow on medium lacking leucine
prevented screening on Leu-enkephalin as the sole source of leucine. Although both
OPT family members and the mammalian enkephalin transporter located at the BBB
have a wide range of substrates, their total potential peptide substrates do not
necessarily overlap. Therefore, not being able to directly screen for enkephalin uptake
was not optimal for selecting a gene encoding an enkephalin transporter.
In addition, one of the benefits of conducting this screen in a non-native cell type is
also a draw-back: while there are no rat proteins in yeast that may interfere with the
transporter, proteins and rat-specific co-factors it may require are also absent. There
may even be post-translational modifications that S. cerevisiae is unable to perform that
are required for the rat transporter’s function, or differences in the membrane may be
prohibitive. A similar case is that of the human Ptr2p homologues. Although the
protein sequence of this peptide transporter family is conserved from bacteria to man,
the human PTR members will not function when expressed in S. cerevisiae. When
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expressed in the heterologous system Pichia pastoris, however, they will transport
peptide (Doring et al. 1997). Furthermore, early observations of PTS-1 showed that it
was sodium-dependent (Banks et al. 1986); there was sodium in the poor nitrogen
medium used, although perhaps not enough. Additionally, Banks et al. (1986) observed
that a tyrosine is required at the N-terminus of substrates of PTS-1. Regrettably, none
of the peptides used in the lysine-based screen had a tyrosine in this position. The
sodium dependency and the required N-terminal tyrosine on utilizable substrates appear
to be the only difference between the OPT family and PTS-1 in rats and mice.
There was no elegant way to screen the cDNA library for proteins conferring the
ability to grow on glutathione. Although not a detriment to the functional augmentation
screen, this perhaps would have added to potential findings,. Not only was the
oxidation state of the cell a problem, but also the gene knock-outs that would have
been required to eliminate the cells’ ability to synthesize glutathione would have
required supplements of sulfur-containing amino acids and other sulfur-metabolizing
genes would have likely interfered. What was unexpected was that nothing was found
that permitted utilization of the peptides KLLG and KLLLG: neither a peptide
transporter and nor an extracellular peptidase that would have permitted utilization of
the peptides.
Members of the organic anion transporting polypeptide superfamily (Oatp/OATP;
TCDB #2.A.60) mediate the translocation of such anions as bile salts, hormones,
eicosanoids, drugs, toxins, peptides, and other organic anions and cations. As of late
2003, there were 11 rat, 8 mouse, and 9 human Oatps/OATPs known. The superfamily
is ATP-independent (Li et al. 2000) and is divided into five families, from OATP1 to
OATP5 (Hagenbuch and Meier 2003). New evidence shows that Oatps/OATPs in
subfamily OATP1A that are found at the BBB — rOatp1 and rOatp2 from rat and
hOATP-A from human — facilitate the transport of opiate peptides such as Leuenkephalin, DPDPE, and deltorphin II (Gao et al. 2000). Unlike PTS-1, this uptake is
sodium-independent (Gao et al. 2000), but no correlative study has been done directly
comparing PTS-1 with an Oatp/OATP. It has also been noted that rOatp2 transports
GSH into both the liver and the brain (Gao and Meier 2001). Oatps/OATPs are only
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found in animal genomes (Hagenbuch and Meier 2003), whereas OPTs are only found in
fungal and plant genomes (Chapter 1). It appears that convergent evolution has
occurred: both the OPT and the Oatp/OATP families facilitate the uptake of
oligopeptides and glutathione. One might expect that our strategy to isolate a rat OPT
functional homologue would have uncovered a member of the Oatp/OATP family, but
as mentioned above, not all mammalian proteins complement yeast homologues.
Although considerable effort, time, and resources were put into this screen, no
positive results were obtained. The lack of an OPT homologue was reinforced once the
rat genome was published and no homologue was found.
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Chapter 4
Topology prediction of the Oligopeptide Transport family.
Background and Significance
Families of multiple transmembrane domain (TMD) proteins are often characterized
by conserved motifs and overall functional similarity. G-protein coupled receptors, for
instance, are characterized by having seven TMDs, binding to G-proteins, and
transducing a signal via extracellular ligand binding (Hamm 1998). Channels and
permeases are characterized by substrate specificity, energy source, and location of
conserved domains in relation to TMDs (Payne and Smith 1994). With a full quarter of
the yeast proteome estimated to be membrane-spanning (Bill 2001), understanding how
TMD proteins operate is imperative to understanding how the cell ultimately functions.
To gain a clear idea of how individual TMD proteins operate, one needs to determine
their tertiary structure — their orientation in the membrane — and the location of
their vital amino acid residues.
Current studies of most proteins at the biochemical level involve determining their
tertiary structure before further characterization. Unfortunately for those studying
transmembrane proteins, techniques such as X-ray crystallography and NMR are limited
in use due to the hydrophobicity, and often large size, of these proteins (von Heijne
1999). There have been a token few prokaryotic transporter and channel proteins,
however, that have had their three-dimensional structures solved (Doyle et al. 1998;
Luecke et al. 1999; Kolbe et al. 2000; Abramson et al. 2003), but as compared to the vast
number of proteins in this class, these structures can hardly be expected to represent all
proteins of this type.
The presently accepted methods of determining location of TMDs and their
orientation in the membrane are chimera construction, antibody binding, glycosylation
determination, and random or directed protein cleavage. Chimera construction is the
most common. Truncations of the gene are made at various points, and the new 3’
ends are fused with a sequence encoding a reporter protein, such as genes for
galactokinase (Green et al. 1989), β-lactamase (Cartwright and Tipper 1991), or Suc2p
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(Gilstring and Ljungdahl 2000). The protein chimeras are then expressed and the
glycosylation state determined (in the case of galactokinase) or enzymatic activities
assayed (in the cases of β-lactamase and Suc2p) on both whole cells and membrane
preparations. Raising antibodies against a protein can be costly in time and money —
Fur4p is one of the rare proteins whose topology has been determined in this way
(Garnier et al. 1996). Again, both whole cells and membranes are analyzed.
Glycosylation state is an indicator of membrane protein topology: membrane proteins
are glycosylated exclusively on the extracellular face. Glycosylation was one method by
which the topologies of both Fur4p (Garnier et al. 1996) and Gap1p (Gilstring and
Ljungdahl 2000) were determined. The glycosylation state of Fur4p was not determined
in S. cerevisiae but the protein was reconstituted in canine pancreatic microsomes
instead.
Problems arise, however, with these techniques: protein truncations or chimeras
may be mis-folded, mis-localized, down regulated, or mis-inserted into the membrane.
Indeed, Cartwright and Tipper (1991) had to express Ste2p-βla fusion in a strain
background that reduced the turnover rate of mis-folded proteins. They chose Ste2p as
their subject because its hydrophobicity was highly suggestive of a seven TMD protein,
and therefore they assumed it would be a relatively simple test case for their method.
Random or directed cleavage is problematic in larger, multiple-pass TMD proteins such
as transporters and channels: it is not known how much of these proteins are solvent
accessible, and this approach is not practical. Even under optimal circumstances, TMD
boundaries are difficult to ascertain by empirical methods (Ott and Lingappa 2002).
For the most part, once there is experimental evidence for one representative of a
polytopic protein family as to where and how many TMDs there are, the findings are
immediately applied to the rest of the family. Here we predict by computer algorithms
the location of TMDs of a relatively new family of transporters, Oligopeptide Transport
Family (OPT), and investigate possible conserved structure. As of yet, the family has no
empirical evidence suggesting topology, and the number of TMDs of this family has
previously only been guessed by various databases to range from nine to 16 — here we
suggest 12.
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Materials and Methods
Protein sequences used.
Protein sequences of six functionally characterized OPT family members, Opt1p and
Opt2p from Saccharomyces cerevisiae; Opt1p from Candida albicans, referred to here as
CaOpt1p; Isp4p from Schizosaccharomyces pombe; Mtd1p from Schizophyllum commune;
and OPT4 from Arabidopsis thaliana, here referred to as AtOPT4 (Table 4-1), were
downloaded from Entrez (www.ncbi.nlm.nih.gov/Entrez/index.html). The ORF
translation of YGL114W from S. cerevisiae was retrieved from the Saccharomyces
Genome Database (SGD; www.yeastgenome.org/). These OPTs were chosen from
among the many family members determined by homology since they have direct
experimental evidence that they are, in fact, oligopeptide transporters, or, the case of
Mtd1p, strong indirect evidence. Ygl114wp was examined because it had been
suggested by others to be an OPT (Yen et al. 2001), although I have shown it has no
transport phenotype (Chapter 1). The sequences of each of the four proteins whose
crystal structures had been solved were retrieved from the Protein Data Bank (PDB;
www.rcsb.org/pdb/).
Programs used.
All 11 proteins were subjected to six separate transmembrane-finding algorithms:
the Kyte-Doolittle hydropathy method (Kyte and Doolittle 1982) run on Protean in
Lasergene® (DNAstar Inc; Madison, WI), TopPred2 (von Heijne 1992; www.sbc.su.se/
~erikw/toppred2/), TMpred ( Hofmann and Stoffel 1993; www.ch.embnet.org/software/
TMPRED_form.html), PHDhtm (Rost et al. 1996; PredictProtein Server at www.emblheidelberg.de/predictprotein/predictprotein.html), TMHMM 2.0 (Sonnhammer et al.
1998; Krogh et al. 2001; www.cbs.dtu.dk/services/TMHMM/), and SVMtm (Yuan et al.
2004; ccb.imb.uq.edu.au/svmtm/svmtm_predictor.shtml). All default settings were used,
and “eukaryotic protein” was chosen when prompted. In PHDhtm, domains specified
with a Best HTM score lower than 0.600 were designated as putative. These algorithms
were chosen as being those available for public use that were designed to predict TMDs
in eukaryotic proteins.
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Table 4-1. Proteins used in this study. Sequences of members of the OPT
family were downloaded from Entrez at their given accession numbers. Sequences and
structures of proteins of known structure were downloaded from PDB at their given ID
number.

OPT (OligoPeptide Transport) Family
Protein
Species
Opt1p
Saccharomyces cerevisiae
Opt2p
Saccharomyces cerevisiae
AtOPT4
Arabidopsis thaliana
CaOpt1p
Candida albicans
Isp4p
Schizosaccharomyces pombe
Mtd1p
Schizophyllum commune
Bacterial Polytopic Proteins
Protein
Species
+
K channel
Streptomyces lividans
Bacteriorhodopsin
Halbacterium salinarum
Halorhodopsin
Halbacterium salinarum
LacY
Escherichia coli

Accession number
NP_012323
NP_015520
AAN15658
EAK99436
NP_595653
AAF26618
ID number
1BL8
1C3W
1E12
1PV6
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Kyte-Doolittle calculates a hydropathy score for each amino acid and averages them
in a sliding window, which was set as nine. TopPred2 predicts topology based on
hydrophobicity and includes the positive-inside rule (von Heijne 1986). The output is
set to only yield TMDs of exactly 21 residues. TMpred not only uses hydrophobicity,
but scores a combination of characteristics, including using residues predicted to be in
all TMD proteins, residues in regions flanking TMDs, and species and homology specific
residue weights. PHDhtm is a trained neural network, TMHMM 2.0 a hidden Markov
model, and SVMtm a support vector machine function. Since the main fault of computer
algorithm prediction methods is the assignment of signal sequences as false-positives, the
signal sequence prediction algorithm SignalP 3.0 was used (Bendtsen et al. 2004;
www.cbs.dtu.dk/services/SignalP/). iMol (www.pirx.com/iMol/) was used to determine
the boundaries of membrane-spanning segments of crystal structure proteins.
The six OPT members were aligned using Clustal W in the program MegAlign in
Lasergene®. DrawTree in Phylip (evolution.genetics.washington.edu/phylip.html) was
used to create an unrooted tree of the selected family members.
Family transmembrane domain prediction.
A consensus for each potential transmembrane segment in each protein was
determined and, in the case of OPT family members, superimposed on the multiple
sequence alignment. The borders of each potential transmembrane region were finetuned with attention paid to specific algorithmic outputs and conserved regions of each
family; this was done in an attempt to keep TMD prediction consistent in relation to
conserved residue location. A more thorough explanation is given in the results section
of this chapter.
Results
Transmembrane domain predictions of proteins with known
structure.
To test the authenticity of the consensus approach, four multiple-pass
transmembrane proteins with solved crystal structures were chosen from PDB (Table
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4-1). The protein sequences that had been deposited were submitted to the six TMD
prediction methods used in this study. A consensus for each potential TMD was
determined (Figure 4-1). These were then compared to the helices as described in each
of the PDB files.
As can be seen in Figure 4-1A, our consensuses agree with the location of the αhelices that cross the membrane as reported by Doyle et al. (1998) for the K+ channel
(1BL8). The crystal structure’s second α-helix does not appear to cross the membrane;
both PHDhtm and TMHMM 2.0, algorithms that have a better probability of correctly
identifying TMDs than Kyte-Dootlittle, TopPred2, or TMpred, incorrectly assigned that
helix as a TMD. In B (bacteriorhodopsin) and C (halorhodopsin) of Figure 4-1, the
consensus approach correctly found the TMDs designated by Luecke et al. (1999)
(1C3W) and Kolbe et al. (2000) (1E12) as α-helices, although for halorhodopsin, the
consensus TMDs tend to be offset toward the C-terminus. SVMtm did not predict any
TMDs for halorhodopsin until the first two residues were removed from the submitted
sequence. It is clear that not all methods correctly predicted all 12 TMDs of LacY
(1PV6) (Figure 4-1.D), but our consensus method found their locations. The particular
shortcoming of TMpred, PHDhtm, and TMHMM 2.0 was TM10, with its helical region
between S311 and F341 (Abramson et al. 2003). Since the assignments of the KyteDoolittle method, TopPred2, and especially SVMtm, and also because of the sequence
we designated as TM9, we specified TM10 to be between V315 and F334.
Determination of signal sequences in the OPT family.
The major problem with algorithmic TMD prediction methods is that they falsely
assign signal sequences that do not span the membrane as TMDs (Moller et al. 2001).
For this reason, all OPT members in this study were submitted to SignalP 3.0 (Bendtsen
et al. 2004) to determine, albeit computationally, if any contained any signal peptides;
they did not.
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Figure 4-1. Transmembrane domain predictions for integral
membrane proteins with solved crystal structures. The alignment was
constructed with ClustalW in MegAlign from Lasergene®. Each protein (A, B, C, and D)
is first represented on six lines corresponding to each algorithm used to predicted its
topology, from top to bottom: Kyte-Doolittle hydropathy, TopPred2, TMpred,
PHDhtm, TMHMM 2.0, and SVMtm. Regions predicted to be TMDs are highlighted in
black — those that have been labeled as putative in grey. TMHMM 2.0 and SVMtm do
not list putative domains. The protein is then represented on another two lines, the
first of which contains highlighted areas of consensus predictions, the second containing
helical regions found in its crystal structure. The sequence ruler is located above each
sequence segment. A. K+ channel (1BL8) (Doyle et al. 1998). In the crystal structure,
the second helix appears to be embedded in the membrane but does not cross it. B.
Bacteriorhodopsin (1C3W) (Luecke et al. 1999). C. Halorhodopsin (1E12) (Kolbe et al.
2000). In the crystal structure, the eighth helix (NNERT) is not a transmembrane
domain. D. LacY (1PV6) (Abramson et al. 2003). According to the crystal structure,
residues N165, G287, and G377 (shown by small arrows) are each assigned to two
different, adjacent α-helices that cross the membrane in opposite directions. The three
helices that do not appear to be embedded in the membrane (M1-N6, S209-Q219, and
S407-A417) have been omitted from this figure for clarity.
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A. K+ Channel
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1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ

Kyte-Doolittle
TopPred 2
TMpred
PHDhtm
TMHMM 2.0
SVMtm
Our prediction based on consensus
Helices found in crystal structure

B. Bacterorhodopsin
1
1
1
1
1
1
1

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+
TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF

1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF
151
151
151
151
151
151
151

---------+---------+---------+---------+---------+---------+---------+-GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG
GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG
GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG
GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG
GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG
GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG

151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG

C. Halorhodopsin
1
1
1
1
1
1
1

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+
AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF

1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF
151
151
151
151
151
151
151

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+--FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD

151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD
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D. LacY, lactose permease
1
1
1
1
1
1
1

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG

1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG
151
151
151
151
151
151
151

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+
WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS

151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS
301
301
301
301
301
301
301

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+------VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA

301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA
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Transmembrane domain predictions of the OPT family.
Since our consensus approach of TMD prediction seemed valid with little ambiguity,
we applied a variation of it to the OPT family — a protein family with no empirical
evidence for its structure to date. Each protein selected (Table 4-1) has had some
functional study done indicating that it is an OPT. Of the six representatives, Mtd1p is
the most distant relative (Figure 4-2); its conserved regions are the most divergent.
As was done for the four proteins with crystal structures, each OPT member was
submitted to the six prediction algorithms, but before a consensus was achieved for
each potential TMD, a global multiple-sequence alignment was performed (Figure 4-3).
A consensus was reached for each TMD in individual proteins only after it was
compared to the conserved regions specified by the global alignment and the algorithmic
predictions made for the rest of the family. For example, when determining the borders
of TM-A (Figures 4-3), it was noted that position 169 on the consensus ruler was
aromatic in all proteins except Mtd1p. If this TMD was predicted by an algorithm,
residue 169 was included. More than half of the algorithms also predicted residue 168,
but only 12 algorithm results extended this TMD more N-terminal. These 12 results
were distributed over all six proteins. The N-terminal end of TM-A was therefore
predicted to be at consensus residue 168 for all six proteins. Similarly, the consensus
residues 185 and 186 were phenylalanines in all proteins except Mtd1p, where 186 was
a tyrosine. More than half of the algorithm results contained these two residues in the
first TMD, but only 14 results extended the TMD more C-terminal, thus the C-terminal
end of TM-A was predicted to be at consensus residue 186 for these proteins. The
Kyte-Doolittle method is notorious for not predicting ends of TMDs well, because it
was not created to carry out this function. TopPred2 was also not designed to predict
borders; it always returns a result of exactly 21 residues, so it cannot be relied upon to
predict the ends of TMDs. PHDtm, TMHMM 2.0, and SVMtm were written with “cap”
functions, so these three were relied more heavily upon for predicting the ends of
TMDs.
Of the 12 TMDs we have assigned to the OPT family, lettered A-L (Figure 4-3), only
six were predicted with certainty by all algorithms in all six proteins. Although TMHMM
80

Figure 4-2. Rooted tree of selected OPT family members. ClustalW in
MegAlign from the package Lasergene® and DrawGram from the phylogeny package
Phylip were used to create this tree. Mtd1p is from S. commune, Opt1p and Opt2p are
from S. cerevisiae, CaOpt1p is from C. albicans, Isp4p is from S. pombe, and AtOPT4 is
from A. thaliana.
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Figure 4-3. Alignment of selected OPT family members and the
transmembrane domain predictions by individual algorithms. The
alignment was constructed with ClustalW in MegAlign from Lasergene®. Each family
member studied is represented on six lines corresponding to each algorithm used to
predict its topology, from top to bottom: Kyte-Doolittle hydropathy, TopPred2,
TMpred, PHDhtm, TMHMM 2.0, and SVMtm. Regions predicted to be TMDs are
highlighted in black — those that have been labeled as putative in light grey. In TMpred,
represented on the third line, residues marked with a small arrow are those that
overlap two designated domains (Isp4p A511, AtOPT4 N644 and Y645). Neither
TMHMM 2.0 nor SVMtm list putative domains. The consensus ruler is located at the
top line of each page. Highlighted in black are the regions proposed to be conserved
TMDs in the family; these are lettered A-L. Also boxed in on the consensus ruler are
the two proline motifs PG[R/K]P and PPX[N/T]p.
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Opt1p
Opt1p
Opt1p
Opt1p
Opt1p
Opt1p

1
1
1
1
1
1
1

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+-------A-+---------+---------+--B------+---------+---------+---------+---------+
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVRSAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVRSAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVRSAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVRSAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVRSAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVRSAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG

Opt2p
Opt2p
Opt2p
Opt2p
Opt2p
Opt2p

1
1
1
1
1
1

MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVRAVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INID
MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVRAVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INID
MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVRAVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INID
MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVRAVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INID
MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVRAVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INID
MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVRAVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INID

AtOPT4
AtOPT4
AtOPT4
AtOPT4
AtOPT4
AtOPT4

1
1
1
1
1
1

-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVRLTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG
-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVRLTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG
-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVRLTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG
-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVRLTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG
-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVRLTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG
-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVRLTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG

CaOpt1p
CaOpt1p
CaOpt1p
CaOpt1p
CaOpt1p
CaOpt1p

1
1
1
1
1
1

-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVRAAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG
-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVRAAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG
-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVRAAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG
-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVRAAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG
-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVRAAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG
-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVRAAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG

Isp4p
Isp4p
Isp4p
Isp4p
Isp4p
Isp4p

1
1
1
1
1
1

----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG
----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG
----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG
----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG
----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG
----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG

Mtd1p
Mtd1p
Mtd1p
Mtd1p
Mtd1p
Mtd1p

1
1
1
1
1
1

-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG
-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG
-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG
-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG
-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG
-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG

Opt1p
Opt1p
Opt1p
Opt1p
Opt1p
Opt1p

241
172
172
172
172
172
172

--------C+---------+---------+---------+-----D---+---------+---------+---------+---------+---------+---------+E--------+---------+---------+---------+---------+---------+---------+---------+-----F---+---------+---------+---------+---------+
-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN
-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN
-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN
-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN
-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN
-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN

Opt2p
Opt2p
Opt2p
Opt2p
Opt2p
Opt2p

233
233
233
233
233
233

KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH
KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH
KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH
KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH
KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH
KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH

AtOPT4
AtOPT4
AtOPT4
AtOPT4
AtOPT4
AtOPT4

105
105
105
105
105
105

-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN
-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN
-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN
-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN
-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN
-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN

CaOpt1p
CaOpt1p
CaOpt1p
CaOpt1p
CaOpt1p
CaOpt1p

155
155
155
155
155
155

-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ
-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ
-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ
-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ
-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ
-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ

Isp4p
Isp4p
Isp4p
Isp4p
Isp4p
Isp4p

159
159
159
159
159
159

-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN
-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN
-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN
-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN
-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN
-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN

Mtd1p
Mtd1p
Mtd1p
Mtd1p
Mtd1p
Mtd1p

157
157
157
157
157
157

-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT
-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT
-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT
-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT
-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT
-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT

83

Opt1p
Opt1p
Opt1p
Opt1p
Opt1p
Opt1p

481
398
398
398
398
398
398

---------+---------+---------+G--------+---------+---------+---------+---------+---------+---------+---------+--H------+---------+---------+I--------+---------+---------+---------+---------+---------+---------+---------+--J------+---------+
KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV
KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV
KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV
KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV
KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV
KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV

Opt2p
Opt2p
Opt2p
Opt2p
Opt2p
Opt2p

450
450
450
450
450
450

SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL
SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL
SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL
SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL
SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL
SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL
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TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI
TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI
TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI
TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI
TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI
TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI
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TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI
TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI
TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI
TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI
TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI
TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI

Isp4p
Isp4p
Isp4p
Isp4p
Isp4p
Isp4p

382
382
382
382
382
382

SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI
SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI
SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI
SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI
SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI
SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI
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VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY
VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY
VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY
VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY
VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY
VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY
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---------+---------+---------+---------+---------+------K--+---------+---------+---------+---------+---------+---------+---------+---------+-L-------+---------+---------+---------+---------+---------+---------+
GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW
GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW
GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW
GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW
GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW
GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW
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GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP
GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP
GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP
GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP
GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP
GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP
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TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP
TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP
TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP
TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP
TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP
TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP
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AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW
AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW
AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW
AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW
AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW
AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW

Isp4p
Isp4p
Isp4p
Isp4p
Isp4p
Isp4p

590
590
590
590
590
590

GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR
GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR
GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR
GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR
GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR
GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR
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VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS
VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS
VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS
VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS
VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS
VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS
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2.0 does not report putative TMDs, occasionally it is clear from the output graph that
there are areas that have scored only slightly below threshold. One such area was
found in Isp4p where TM-B has been assigned. TM-C was weakly predicted in both
Opt2p and Isp4p, although designated as a membrane-spanning domain in the rest of the
family. TMHMM 2.0 also yielded a weakly predicted area in this region. An area
between TM-E and -F was very weakly predicted by the algorithms as a whole. This
area in Opt1p and Opt2p contains scores below the threshold of TMHMM 2.0. Neither
PHDhtm nor SVMtm predicted any TMDs in this region.
The areas marked in grey on the consensus ruler in Figure 4-3 are two proline
motifs, which we did not assign to be TMDs. The consensus of the first marked proline
motif is PG[R/K]P. In Opt1p, the Kyte-Doolittle method and PHDhtm designated
residues to be part of a TMD, while TMHMM 2.0 showed a score to be slightly below
threshold for this region. In Opt2p, only PHDhtm suggested a putative domain, and
TopPred2 and PHDhtm suggested a putative domain in Mtd1p. The area around the
PGNP in Opt2p is predicted by all methods, but spread over 32 residues. The area
around the GGRP in CaOpt1p and the PGRP in Isp4p is predicted, at least putatively, by
every method. These predictions, however, are spread over 38 residues in CaOpt1p
and 47 in Isp4p.
The consensus of the second marked motif is PPX[N/T]p, which is not found in
Mtd1p (Figure 4-3). The lowercase “p” in the motif is not found in the motif as
described in Chapter 1, but is conserved among the proteins in this study. Overall, this
region (residues 806 to 850, consensus ruler) was more consistently predicted as a
transmembrane region than the region including the PG[R/K]P motif, but neither region
containing PPX[N/T]p or PG[R/K]P was considered to be a TMD in our consensus
because of the proximity of the prolines.
Conservation of charged and hydrophobic residue location may easily be viewed in
Figure 4-4. In our model, most, but not all, of the eighteen conserved motifs discussed
in Chapter 1 fall outside of the membrane-spanning areas. Something, which in
retrospect should not be surprising due to the work of Sipos and von Heijne (1993),
was revealed after all TMD assignments had been made: on either side of the boundaries
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Figure 4-4. Alignment of selected OPT family members and the
locations of their transmembrane domains as predicted by familial
alignment. The alignment was constructed with ClustalW in MegAlign from
Lasergene®. The color code for amino acid residue groups (for non-transmembrane and
consensus transmembrane domains respectively) is as follows: hydrophobic, dark green
and light green; basic, dark blue and light blue; acidic, red and pink; proline, yellow and
cream; other, dark grey and light grey. The consensus ruler is found at the top, and the
regions highlighted black are the consensus transmembrane domains for these select
family members, while regions boxed are the proline motifs PG[R/K]P and PPX[N/T]p.
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Opt1p
Opt2p
AtOPT4
CaOpt1p
Isp4p
Mtd1p

1
1
1
1
1
1
1

---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+
-----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVR
MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVR
-------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVR
-----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVR
----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVR
-----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVS

151 ---------+-------A-+---------+---------+--B------+---------+---------+---------+---------+--------C+---------+---------+---------+-----D---+---------+
Opt1p 92 SAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGY
Opt2p 151 AVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INIDKPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGF
AtOPT4 20 LTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGY
CaOpt1p 77 AAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGF
Isp4p 77 AAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGY
Mtd1p 68 RYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGM
Opt1p
Opt2p
AtOPT4
CaOpt1p
Isp4p
Mtd1p

301
227
289
164
212
214
212

---------+---------+---------+---------+---------+E--------+---------+---------+---------+---------+---------+---------+---------+-----F---+---------+
GAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVI
GFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALI
GWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYF
AFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWI
GLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWI
GLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYV

Opt1p
Opt2p
AtOPT4
CaOpt1p
Isp4p
Mtd1p

451
369
422
296
351
353
348

---------+---------+---------+---------+---------+---------+G--------+---------+---------+---------+---------+---------+---------+---------+--H------+
VLPCLYF-TNTWYAKYMPVISGSTYDNTQNKYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQI
VI-AVYY-SNYMSCQYLPIFTNSLYTNTGHSFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILI
VLPLAYWGFDSYNATRFPIFSSHLFTSVGNTYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLA
VVPAIHY-SNTWYSQYLPISSTGSFDRFQQTYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFL
VTPALNF-TNTWYGDYLPISSSGIIDHFGNSYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFL
IMAAIYY-SNAWDSKNYKMLSTSIFNHNGTVYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLF

Opt1p
Opt2p
AtOPT4
CaOpt1p
Isp4p
Mtd1p

601
491
565
418
471
472
472

---------+---------+I--------+---------+---------+---------+---------+---------+---------+---------+--J------+---------+---------+---------+---------+
VMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNVGVQEWMMHNIDGLCTTDQP---NGFTCANG
GSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNLGVLNWQISNIKDFCTPHQN---AKFTCPDA
ATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINITVAWWQLNSIKNICQEELLPPNSPWTCPGD
VFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQIAVLEWAYGAIDNLCAADQK---NHYTCPNG
AFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQIGVLDWALGNIDNVCQADQP---DNYTCPNA
LAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNYVVMISIVDAQREVLLDASG--TNVWSGQTI

Opt1p
Opt2p
AtOPT4
CaOpt1p
Isp4p
Mtd1p

751
636
710
568
616
617
618

---------+---------+------K--+---------+---------+---------+---------+---------+---------+---------+---------+-L-------+---------+---------+---------+
RTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVW
VTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVP
RVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGE
KVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVI
TVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGA
QSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PA

Opt1p
Opt2p
AtOPT4
CaOpt1p
Isp4p
Mtd1p

901
774
848
709
757
757
762

---------+---------+---------+
KRTYDNDYKK--FYTLKKGETFGYDKWW
YAGADGVGYPLKNITDTANGYFGYAPGHYP
HCDLAKCPTA--RGVIVDGCP
NTTLDTQVVTNIRHILKEGEAFGPSSW
FNTLDATGAA-VRKLVNESAR
KGNIDYCNGN---GALDAS
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of the TMDs were frequently tryptophans, phenylalanines, and tyrosines. von Heijne has
noted that there are frequently aromatics, specifically tryptophans and phenylalanines, at
the ends of membrane-spanning segments — at the interface between the membrane
and the aqueous environment. TMs B, C, D, F, G, and L do not have conserved
aromatic residues flanking them (Figure 4-4), but often non-conserved aromatic residues
are located at the border. In every member studied, TM-E is full of aromatic residues.
Prediction of topological orientation of the OPT family.
The distribution of the positively charged amino acids arginine and lysine were
examined in our OPT family TMD model (Table 4-2). The “positive-inside rule” (von
Heijne 1986) states that the location of most arginines and lysines found in nontransmembrane segments is preferentially the cytoplasmic side, although this is less
pronounced in eukaryotes (Sipos and von Heijne 1993). In the OPT family, we see
strong evidence of this after TM-G (in loop 7), which is approximately the middle of the
proteins. In each of the OPTs in this study, more than half of the positively charged
residues are in the C-terminal half of the protein.
In eukaryotes, the “charge-difference rule” is a good predictor of the orientation of
membrane-spanning proteins (Sipos and von Heijne 1993). It states that of the 15
residues on either side of the first TMD, the extra-cytoplasmic residues will have a
greater net negative charge than those in the cytoplasm. In the OPT family, the end of
the first conserved motif, SPYXEVRXV[V/T]X3DDP, falls within 15 residues of the first
predicted TMD. The DD is 92/83% conserved, and often more aspartic acid, or even
glutamic acid, residues are also present nearby. Following this rule, the N-termini of the
family would be extra-cellular.
Discussion
We have determined, via a combination of computational algorithms and multiplesequence alignment, the location of 12 TMDs in the OPT family. Although a similar
study has been conducted by Bertaccini and Trudell (2002) on human ligand-gated ion
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Table 4-2. Charged residues involved in determination of topological
orientation of the OPT family. A. The number of negatively charged residues
and total number of residues in the N-terminus is given for each protein in this study.
The percentage of negatively charged residues is tightly conserved between 23.1 and 25.
B. The number of positively charged residues in the termini and loops shorter than 70.
Loops are numbered starting with those most N-terminal: loop 1 is between TM-A and
-B, loop 2 is between TM-B and -C, etc.

A.
Negative charges in N-terminus
Opt1p
Opt2p
negative
25
40
total
109
168

AtOPT4
9
36

CaOpt1p
22
94

Isp4p
23
94

Mtd1p
20
85

B.
Positive charges
loop
Opt1p
Opt2p
AtOPT4 CaOpt1p
Isp4p
Mtd1p
N-terminus
*
*
2
*
*
*
1
1
1
1
1
0
1
2
4
6
5
2
6
6
3
1
1
2
1
3
1
4
7
8
7
4
9
5
5
2
1
2
1
1
3
6
5
4
3
5
2
3
7
8
9
9
7
5
6
8
1
0
0
0
1
1
9
7
4
5
6
5
6
10
3
4
4
3
3
2
11
9
7
7
7
6
8
C-terminus
8
2
4
2
3
2
* Not relevant with respect to positive-inside rule since this segment is greater than 70
residues long.
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channels, never before has such been done over such a diverse family or over multiple
species.
The TMDs of four multiple-pass TMD proteins with solved crystal structures were
correctly predicted by the consensus approach. The use of multiple algorithms allowed
results for each potential membrane-spanning region to be confirmed or rejected by the
other algorithms. Indeed, it has been suggested that compiling several algorithms
improves the prediction outcome (Nilsson et al. 2002).
Our model (Figure 4-5) shows that the conserved residues of the family (Chapter 1)
fall outside of the TMDs. One would expect highly conserved residues to reside in
conserved locations with respect to the membrane. If a region of a protein has had
selective pressure placed on it so that it had been retained throughout evolution, the
region likely has functional or structural significance. One would not anticipate an area
such as this to be located in the middle of the membrane in one family member while
being more exposed in the loop of another member that carries out a similar function.
Indeed, one would even go so far as to say one would expect a family to retain a similar
topology.
The conserved proline motifs EXIXGYX2PG[R/K]PXAX4KX2G and PPX[N/T]p have
been assigned to loop regions found on the same side of the membrane. Four of the
OPTs in this study have yet another proline at the end of the PPX[N/T]p motif. These
regions are perhaps SH3 binding domains, which are characterized by the motif PXXP
(Mayer 2001). When PDB was searched for the sequence PGRP, 29 structures were
found which contain the sequence; 18 of these were unique. In each of these
structures, a bend in the backbone occurred at the glycine, and about half of the time,
the flanking sequences folded in a hairpin configuration. We propose a similar structure
in the OPT family. Since the conserved region is E(X)7PG[R/K]P(X)6K, where X is
almost always hydrophobic and never charged, the charged glutamyl and lysyl residues
would bee brought together to form a potential ionic interaction, stabilizing the loop.
Our predicted topology places both the N- and C-termini outside of the cell (Figure
4-5). Although this positions a similar number of positive charges inside versus outside
of the cell, the concentration of negative charge immediately prior to the first TMD
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Figure 4-5. Diagram of Opt1p topology. Our model places the termini in the
extracellular space. TMDs are labeled A through L, while loops connecting the TMDs
are numbered 1-11. Positively and negatively charged residues are shaded blue and red,
respectively; aromatic residues are shaded green. Conserved motifs (Chapter 1, Figure
1-2) are circled with orange.
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strongly suggests that the N-terminus is extracellular. Not only is the N-terminal region
immediately adjacent to TM-A highly negatively charged, but also the whole N-terminus
is greatly negatively charged. In the six OPT family members studied, aspartyl and
glutamyl make up from 23.1% to 25% of the N-terminal segment — even the percentage
of acidic residues is conserved! Five of these six family members have over 80 residues
in the N-terminus (AtOPT4 is the exception, with 36). Perhaps this large negative
charge serves to balance the positively charged residues found in the outer loops (Figure
4-5). Since these are transporters of charged peptides, we can imagine that both the
excess positive charges in the loops and the abundance of negatively charged residues in
the N-terminus are involved in recognition and binding of oligopeptides.
Frequently, the boundaries of the TMDs are composed of aromatic residues. Sipos
and von Heijne (1993) have suggested this serves to stabilize the TMD at the
hydrophilic-hydrophobic interface. More than half of the tryptophan, phenylalanine, and
tyrosine residues present in Opt1p are located within five residues from the edge of the
transmembrane segment (Figure 4-5). Only TMs D, E, and F contain three or more of
these residues in their core. Perhaps the juxtaposition of these more aromatic TMDs
provides interaction with the substrate, or perhaps it allows them to simply stabilize
each other.
Our predicted topology of the OPT family (Figure 4-5) is not necessarily the only
possible model. Although Sipos and von Heijne (1993) state that the charge-difference
rule is likely a better predictor of topology in eukaryotes than the positive-inside rule is,
we show almost an equal number of positive charges on both faces of the proteins
(Table 4-2). There are two ways to fix this problem: either omit TM-E or bend it so it
does not pass through the membrane but exits the same side from which it entered.
Since TM-E is very strongly predicted (Figure 4-4), perhaps the later conformation is
more likely. TM-E does contain a conserved proline, often followed by a glycine, which
may induce a bend in the helix. It also contains more aromatic residues in the core of
the TMD than any other TMD in the protein; this suggests that it may not go through
the middle of the membrane but remain at the membrane interface.
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When comparing results of the S. cerevisiae protein Ygl114wp, which Milton Saier
has classified as an OPT (Yen et al. 2001; tcdb.ucsd.edu/index.php), to the rest of the
family’s topology prediction, they are not at all consistent with Ygl114wp being a family
member (data not shown). First of all, since most of the conserved domains of the OPT
family are absent from Ygl114wp, an alignment is weak at best. The overall topology of
Ygl114wp is strikingly different in the size and location of the extra- and intracellular
loops.
It is obvious that individual algorithms are insufficient for the determination of even a
initial secondary structure prediction of transporters residing in the membrane. For the
first time, the employment of multiple algorithms combined with a multiple sequence
alignment can yield a prediction in which confidence can be placed and may be used as a
basis for hypothesis-driven experiments that can lead to a more accurate structure. But
for now, from the data gathered from proteins with known structure, we likely have a
good model for the OPT family. Now what awaits is empirical evidence to support our
consensus approach.
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Chapter 5
Summary and conclusions.
Members of the Oligopeptide Transport (OPT) family are integral membrane
proteins that transport tetra- and pentapeptides — and some of them glutathione or its
derivatives — across the plasma membrane. Our laboratory first identified the OPT
family in Candida albicans by phenotype (Lubkowitz et al. 1997), and later homologues
were identified by sequence similarity and their subsequent cloning (Lubkowitz et al.
1998; Hauser et al. 2000; Koh et al. 2002). Specifically, one of the family members found
in Saccharomyces cerevisiae, Opt1p, transports the pentapeptide Leu-enkephalin (Tyr-GlyGly-Phe-Leu) and reduced glutathione (γ-Glu-Cys-Gly). This uptake can be inhibited by
other tetra- and pentapeptides and ligands of opioid receptors, such as morphine and
naloxone, but not inhibited by di- or tripeptides or by free amino acids.
Currently, there are 103 OPT members identified by sequence homology: 81 in
fungal species and 22 in plant. If an OPT is found in a completed genome, there is a
multiplicity of OPT members in that genome. OPTs have been found only in fungal and
plant species — our screen for a functional homologue of Opt1p from S. cerevisiae in rat
yielded no peptide transporters. Members of the family are identified by 18 conserved
motifs stretching across almost the entire primary sequence, from before the first
predicted transmembrane domain (TMD) until after the last; these conserved motifs are
at least four residues long. By a combination of familial, global alignment and numerous
computational algorithms, we predict 12 TMDs in the OPT family, with the termini
placed outside of the cell because of the charge-difference rule.
The gene encoding Opt1p in S. cerevisiae, OPT1, is regulated by sulfur source and
amino acids. When grown without sulfate, cells up-regulate OPT1. When this sulfur is
added back in the form of cysteine, OPT1 is no longer up-regulated, and when media is
supplemented with methionine, OPT1 is down-regulated. All other amino acids upregulate OPT1, presumably through Ssy1p and Ptr3p, since no up-regulation is observed
when the proteins are not present.
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Future Directions
The next step in the further study of the OPT family is to test our TMD predictions.
Antibodies could be designed to the N- and C-termini to check their intra- versus
extracellular locations, or a reporter protein could be used to tag the end to determine
the location of the C-terminus. Chimeric and mutational analyses could be performed,
but it would be wise to consider using several methods and to position the truncations
and mutations at various points along the predicted loops. Additionally, the possibility
of the two proline motifs being SH3 binding domains needs to be investigated.
The roles of the other conserved motifs may also be examined. These may confer
specificity for substrate, couple transport with the symport of protons as an energy
source, or be involved in the protein’s regulation and post-translational modification.
A thorough alanine-scanning of these residues by site-directed mutagenesis is bound to
reveal the function of at least some of these motifs.
In addition, further studies of OPT regulation need to be carried out with regards to
OPT2. Gasch et al. (Gasch et al. 2000) made the observation that OPT2 was up-regulated
during stationary phase, although we did not observe this when cells were grown up to
48 hours. Boer et al. (Boer et al. 2003) made no observations on OPT2 since it
apparently was not included on their microarray — a common problem with genes on
the second arm of the sixteenth chromosome. A wider variety of nitrogen, sulfur, and
carbon sources should be tried, as well as samples from close time-points over several
days.
Although it appears that the protein encoded by YGL114W is not an oligopeptide
transporter, it is obviously plays an important role in cell growth: ygl114wΔ cells have a
doubling time of six hours, instead of two, and do not divide as many times as wild-type
cells. It is likely either involved in cell division or nutrient utilization, or perhaps even
cell aging. The first experiment to begin investigation of this protein’s function is
microarray analysis comparing a ygl114wΔ strain to a wild-type strain.
Perhaps the most interesting line of inquiry involves the role of the seven OPTs in C.
albicans. CaOpt1p is known to transport KLGL; it is not known what the substrates of
the other six might be: tetra- and pentapeptides, glutathione, or perhaps both. Isp4p
96

from Schizosaccharomyces pombe and Mtd1p from Schizophyllum commune were both
identified by their expression under conditions in which cells mate. Three OPTs in C.
albicans are up-regulated in the opaque phase of this organism, the only phase in which
C. albicans has been observed to mate. Perhaps these OPTs are required for mating, or
even required to switch to the opaque phase. These three OPTs are also up-regulated
in C. albicans when the cell has been engulfed by a macrophage, which has an implication
that they are involved with virulence. While knocking-out genes in C. albicans is more
difficult than in S. cerevisiae, Reuß et al. (Reuß et al. 2004) have begun knocking these
genes out, and our lab is well equipped to carry out experiments involving white-opaque
switching, mating, and even virulence.
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Appendix 1
Media
All percentages are weight/volume (g/100 mL) unless otherwise noted. If media was
to be used for plates 2% agar was added before autoclaving. Media were tempered at
55 C before the addition any drug, peptide, or pre-made YNB. Filtrations were done
using 0.45 µM, HV Durapore membranes (Stericup, Millipore; Billerica, MA) attached to
a syringe. Unless otherwise noted, compounds were obtained from Difco/BD; Franklin
Lakes, NJ.
E. coli media.
LB
Tryptone (1%), yeast extract (0.5%), sodium chloride (1%). Autoclaved to sterilize.
With ampicillin (LB +Amp): Final concentration 100 µg/mL (stock at 100 mg/mL in 50%
ethanol) (Sigma; St. Louis, MO). Filtered to sterilize.
Yeast media.
YEPD
Yeast extract (1%), peptone (2%), glucose (2%). Autoclaved to sterilize.
With G418/geneticin (for KanMX3 cassette selection): Final concentration 200 µg/mL
(Invitrogen; Carlsbad, CA). Filtered to sterilize.
With hygromycinB (for HphMX4 cassette selection): Final concentration 300 µg/mL
(Sigma; St. Louis, MO). Filtered to sterilize.
With clonNAT (for NatMX4 cassette selection): Final concentration 100 µg/mL
(Werner BioAgents; Jena-Cospeda, Germany). Filtered to sterilize.
Casamino acid medium
Glucose (2%), casamino acids (0.2%). Autoclaved to sterilize. Filter sterilized YNB
without amino acids added to the final concentration 6.7%.
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Poor nitrogen medium
Glucose (2%). Autoclaved to sterilize. Filter sterilized proline added at the final
concentration of 0.1%. Filter sterilized YNB without ammonium sulfate, without
amino acids added to the final concentration 0.17%.
With uracil: when uracil was required for auxotrophic requirements, it was added at
the final concentration of 20 µg/mL. Filtered to sterilize.
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Table A-1. Synthetic complete medium formula and modifications.
Synthetic complete medium (SC), with modifications made for media containing reduced
carbon (r C) or no carbon (no C), reduced nitrogen (r N) or nitrogen (no N), reduced
sulfur (r S) or no sulfur (no S), and reduced nitrogen and sulfur (r NS) or no nitrogen
and sulfur (no NS). The SC formula was first referred to as “nitrogen base for carbon
assimilation tests” but without the listed amino acids, and it assembled as described
(Wickerham 1946; Wickerham 1951). Compounds are listed as mg/L.

Compounds
H3BO3
CuSO4⋅5H2O
CuCl2
KI
FeCl3⋅6H2O
MnSO4⋅1H2O
MnCl2
Na2MoO4⋅2H2O
ZnSO4⋅7H2O
Zn(CH3CO2)2
biotin
calcium pantothenate
folic acid
inositol
niacin
p-aminobenzoic acid
pyridoxine HCl
riboflavin
thiamine HCl
KH2PO4
MgSO4⋅7H2O
MgCl2
NaCl
CaCl2⋅2H2O
glucose
(NH4)2SO4
NH4Cl
Na2SO4

SC
0.5
0.04
—
0.1
0.2
0.4
—
0.2
0.4
—
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
500
—
100
100
20000
5000
—
—

rC
0.5
0.04
—
0.1
0.2
0.4
—
0.2
0.4
—
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
500
—
100
100
2500
5000
—
—

no C
0.5
0.04
—
0.1
0.2
0.4
—
0.2
0.4
—
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
500
—
100
100
—
5000
—
—

rN
0.5
0.04
—
0.1
0.2
0.4
—
0.2
0.4
—
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
500
—
100
100
20000
500
—
4830

no N
0.5
0.04
—
0.1
0.2
0.4
—
0.2
0.4
—
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
500
—
100
100
20000
—
—
5367

rS
0.5
—
0.022
0.1
0.2
—
0.298
0.2
—
0.305
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
50
174.15
100
100
20000
—
4046
—

no S
0.5
—
0.022
0.1
0.2
—
0.298
0.2
—
0.305
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
—
193.5
100
100
20000
—
4046
—

r NS
0.5
—
0.022
0.1
0.2
—
0.298
0.2
—
0.305
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
50
174.15
100
100
20000
—
404.6
—

no NS
0.5
—
0.022
0.1
0.2
—
0.298
0.2
—
0.305
0.002
0.4
0.002
2
0.4
0.2
0.4
0.2
0.4
1000
—
193.5
100
100
20000
—
—
—
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Table A-2. Amino acids added to satisfy auxotrophic requirements or
to test induction of OPT1. Final concentrations of amino acids supplemented to
medium, given in µL/mL.

Amino acid
A
C
D
E
F
G
H
I
K
L
M
N
P
Q
R
S
T
V
W
Y

Final concentration
40
40
100
100
50
40
20
30
30
30
20
40
40
40
20
400
200
150
20
30
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Appendix 2
Strains
Name
FY2
AW1001
AW1002
AW1003
AW1004
AW1005
AW1009
BY4730
BY4730
opt1Δ opt2Δ
BY4742
opt1Δ

Genotype
MATa ura3-52
MATa ura3-52 opt1Δ::KAN
MATa ura3-52 opt2Δ::HPH
MATa ura3-52 ygl114wΔ::NAT
MATa ura3-52 ptr3Δ::NAT
MATa ura3-52 ssy1Δ::KAN
MATa ura3-52 ptr3Δ::NAT ssy1Δ::HPH
MATa leu2Δ met15Δ ura3Δ
MATa leu2Δ met15Δ ura3Δ
opt1Δ::KAN opt2Δ::HPH
MATα his3Δ leu2Δ lys2Δ ura3Δ
opt1Δ

Parent
S288C
FY2
FY2
FY2
FY2
FY2
FY2
FY2
BY4730

Reference
(Winston et al. 1995)
This study
This study
This study
This study
This study
This study
(Brachmann et al. 1998)
This study

FY2

(Brachmann et al. 1998)
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Appendix 3
Plasmids
Name
pDB20

Genotype
URA3 AmpR ADHp

Parent
—

pADH212c

URA3 AmpR ADHp-OPT1

pDB20

pADH194c

URA3 AmpR ADHp-OPT2

pDB20

pADHCaOPT URA3 AmpR ADHp-CaOPT1

pDB20

URA3 AmpR ADHp-YGL114W
Contains the KAN cassette kanMX3,
which is loxP-flanked, conferring
resistance to G418
Contains the NAT cassette natMX4,
conferring resistance to (clonNAT)
Contains the HPH cassette hphMX4,
conferring resistance to hygromycin B
URA3 AmpR lacZ (no promoter)

pDB20
—

pYLZ6-OPT1
pYLZ6-OPT2
pYLZ6YGL114W
pVT102U

URA3 AmpR OPT1p-lacZ
URA3 AmpR OPT2p-lacZ
URA3 AmpR YLG114Wp-lacZ

pYLZ6
pYLZ6
pYLZ6

URA3 AmpR ADHp

—

pVT102Ulib

URA3 AmpR ADHp::rat brain cDNA
library

pADH114w
pUG6
pAG25
pAG32
pYLZ6

pUG6
pUG6
—

Reference
(Becker et al.
1991)
(Lubkowitz et al.
1998)
(Lubkowitz et al.
1998)
(Lubkowitz et al.
1997)
This study
(Gueldener et al.
1996)
(Goldstein and
McCusker 1999)
(Goldstein and
McCusker 1999)
(Hermann et al.
1992)
This study
This study
This study

(Vernet et al.
1987)
pVT102U (Burton et al.
1993)
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Appendix 4
Primers
Primer

Sequence 5’ to 3’

Comments

clone114F

GCATACAACTCCAAGCTTCGAGATGCCTCAATCTAC
TCCAAGTCAAGAAG
GGCGAAGAAGTCCAAAGCTTCGAGCGGCCGCTAATG
TGAGGGACATTTAAGCAGATGAAGAGC
AATATTTCAAGCTATACCAAGC

construction of
pADH114W
construction of
pADH114W
sequence check
pADH114W
sequence check
pADH114W
sequence check
pADH114W
sequence check
pADH114W
YFR029W (PTR3) knockout

clone114R
F_pDB20_insert_
check
R_pDB20_insert_
check
F_114_checkA

GCCGACAACCTTGATTGG
GCTGGGGTGTGTTAGCAC

R_114_checkB

CATCCAGTGATAACGGTGG

KO_029_F

check_029_F

GGTACGAAATACACAACTGATAGGCGTTCATGCACT
CTCACAGCTGAAGCTTCGTACGC
GTGGAATATTTGCTTACATTTGGTGATTTCGCGAGA
TTGGGCATAGGCCACTAGTGGATCTG
CCGTTAAAGATTCTAAATCGGTACTGTAAATACTTT
GAAACAGCTGAAGCTTCGTACGC
CCTAATAGTGAGGGACATTTAAGCAGATGAAGAGCA
TGTTGCATAGGCCACTAGTGGATCTG
GGGAAGTTCCTTGAGGAATATGAGTTCTGTCAACCA
AATACAGCTGAAGCTTCGTACGC
CCCTAAATCAGCCAGGTAACCAACTTCTTCGCTCTT
TCCCGCATAGGCCACTAGTGGATCTG
GGGTTTGTTATACGCAATATTGCTGTTGAATTATTA
GAAACAGCTGAAGCTTCGTACGC
GCGTTCTAAGAAAAGTTCTAGTCATGGATAGTGTCC
TGGAGCATAGGCCACTAGTGGATCTG
GGCAGAAAATAACCGCAACAATTATATAACGTCACA
GAACCAGCTGAAGCTTCGTACGC
CCACCATTTATCATAACCAAATGTCTCACCTTTCTT
TAAGGCATAGGCCACTAGTGGATCTG
CCTTTATCATTATTTCATGAGGCGCAC

check_029_R

GCCACACCTGTGGGGTGAATTGTGG

check_114_F

CGCCGTAGAAGGTATTTTTCGTGAG

check_114_R

GATAGCCGATATTTCAAGGTCGCG

check_160_F

GGAAACAGGCGTGTGATAAGAGGCC

check_160_R

CAGTTACCCGCACAATCTAGTGCG

KO_029_R
KO_114_F
KO_114_R
KO_160_F
KO_160_R
KO_194_F
KO_194_R
KO_212_F
KO_212_R

YFR029W (PTR3) knockout
YGL114W knockout
YGL114W knockout
YDR160W (SSY1) knockout
YDR160W (SSY1) knockout
YPR194C (OPT2) knockout
YPR194C (OPT2) knockout
YJL212C (OPT1) knockout
YJL212C (OPT1) knockout
YFR029W PCR check
knockout
YFR029W PCR check
knockout
YGL114W PCR check
knockout
YGL114W PCR check
knockout
YDR160W PCR check
knockout
YDR160W PCR check
knockout

cont. on next page
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cont. from previous page
Primer
Sequence 5’ to 3’
check_194_F

CATTGAACGTCTAAACAACGGCGGC

check_194_R

CTATAGTACAGAGTTACTTTGATATG

check_212_F

GGGCTATTCAATGAATTGTTTCGAC

check_212_R

GGGGTCGCTTTGAATGTTTCGACC

probe_029_F
probe_029_R
probe_114_F
probe_114_R
probe_160_F
probe_160_R
probe_194_F
probe_194_R
probe_212_F
probe_212_R
212prom_pYLZ_F

114prom_pYLZ_
R
seqcheck_pYLZF

CGGATATAGCGAGGGTGCTCG
CCACAAAGAAAGTCCCCTTTCTG
CAGATAACACTCCGAGCAACC
CACCTAAGACCAACCCCGAACTG
CATGATACTTCGTCCAGCCTTGC
GTTCGGTCCAGTCAGTTCTGTCC
GGTACTGTTGATTACGCCGAGGG
GTATCAGTTATGTTCTTTAGAGG
CGACTCGTTGGAGTCGGAGCCC
CGTTGTTTCCCCACCAGCTGAGC
GCAGCTGAATTCAAAGCTTAGGATCCCTAAATTAAC
CCATTTGTACAGC
CCCAGTCACGACGTTGTAAAACGACCATAATTTCTA
ATAATTCAACAGC
GCAGCTGAATTCAAAGCTTAGGATCCCGTGTCAACT
TTGCATTAACGCG
CCCAGTCACGACGTTGTAAAACGACCATAATTTCTA
ATAATTCAACAGC
GCAGCTGAATTCAAAGCTTAGGATCCCCTAGACCCT
TATTTGAGGCGTG
CCCAGTCACGACGTTGTAAAACGACCATTTCAAAGT
ATTTACAGTACCG
GGAAGAGCGCCCAATACGCAAACCG

seqcheck_pYLZR

CCAGTCACGACGTTGTAAAACGACC

212-lacZ-F

CAAGGGCAGTCGATGGGTCTG

212-lacZ-R

CAGACCCATCGACTGCCCTTG

194-lacZ-F

GGAATGGAACACTATCCTGTG

194-lacZ-R

CACAGGATAGTGTTCCATTCC

114-lacZ-F

GAAGGAAGATAATGCAAAGCC

114-lacZ-R

GGCTTTGCATTATCTTCCTTC

ADHP_F
ADHT_R

CTGCACAATATTTCAAGCTATACC
GGCAAGGTAGACAAGCCGACAACC

212prom_pYLZ_
R
194prom_pYLZ_F
194prom_pYLZ_
R
114prom_pYLZ_F

Comments
YPR194C PCR check
knockout
YPR194C PCR check
knockout
YJL212C PCR check
knockout
YJL212C PCR check
knockout
YFR029W probe
YFR029W probe
YGL114W probe
YGL114W probe
YDR160W probe
YDR160W probe
YPR194C probe
YPR194C probe
YJL212C probe
YJL212C probe
creation of pYLZ6-OPT1
creation of pYLZ6-OPT1
creation of pYLZ6-OPT2
creation of pYLZ6-OPT2
creation of pYLZ6YGL114W
creation of pYLZ6YGL114W
sequence check a promoter
in pYLZ6
sequence check a promoter
in pYLZ6
sequence check pYLZ6OPT1
sequence check pYLZ6OPT1
sequence check pYLZ6OPT2
sequence check pYLZ6OPT2
sequence check pYLZ6YGL114W
sequence check pYLZ6YGL114W
sequence pVT102U inserts
sequence pVT102U inserts

cont. on next page
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Primer
Sequence 5’ to 3’
AD1
AD2
AD3
AD4
AD5
AD6
AD7

Comments
a

CATCGCCATGTTCATGTCCWAYTGGKTNCC
a
TTCATCGCCATGTTCATCTGBWAYTGGKTNC
a
TGTTCATCGCCATGTTCATCTDBWAYRGGKT
a
TGAAGATGTAGCCGGGGAMCCARTWVHA
a
GCAGGTGGTGTACCACACGTYNKTNCCCCACC
a
GCAGGTGGTGTACCACACGKYNKTNCCCCAC
a
CAGGTGGTGTACCACACGTTGKTNCCCCACCA

Forward CODEHOPb
Forward CODEHOPb
Forward CODEHOPb
Forward CODEHOPb
Reverse CODEHOPb
Reverse CODEHOPb
Reverse CODEHOPb

a

The standard single-letter designations for degenerate nucleotides was used: R (A or
G), Y (C or T), M (A or C), K (G or T), W (A or T), S (C or G), B (C, G, or T), D (A,
G, or T), H (A, C, or T), V (A, C, or G), and N (A, C, G, or T).
b
CODEHOPs (COnsensus-DEgenerate Hybrid Oligonucleotide Primers; (CODEHOP:
bioinformatics.weizmann.ac.il/blocks/codehop.html; Rose et al. 1998) were designed
from BLOCKS (bioinformatics.weizmann.ac.il/blocks/). BLOCKS is an algorithm to
which a multiple sequence alignment is submitted, and the output is small regions of high
similarity between sequences entered. These regions are then submitted to the
CODEHOP algorithm, the output being degenerate primers. The OPT family members
used were too divergent to obtain CODEHOPs few degenerate nucleotides. The
mouse codon-bias was selected in designing the primers, since they were to be used in
screening the mouse genome for an OPT homologue.
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